<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Microbiol</journal-id><journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Microbiology</journal-title></journal-title-group><issn pub-type="epub">1664-302X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7411080</article-id><article-id pub-id-type="doi">10.3389/fmicb.2020.01840</article-id><article-categories><subj-group subj-group-type="heading"><subject>Microbiology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bao</surname><given-names>Lirong</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/935893/overview"/></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Cheng</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/993964/overview"/></contrib><contrib contrib-type="author"><name><surname>Dong</surname><given-names>Jiajia</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/941975/overview"/></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Lei</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Yan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sun</surname><given-names>Jianxun</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="corresp" rid="c002"><sup>*</sup></xref></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country></aff><aff id="aff3"><sup>3</sup><institution>Department of Periodontics, West China Hospital of Stomatology, Sichuan University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country></aff><aff id="aff4"><sup>4</sup><institution>Department of Cariology and Endodontics, West China Hospital of Stomatology, Sichuan University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Sven Hammerschmidt, University of Greifswald, Germany</p></fn><fn fn-type="edited-by"><p>Reviewed by: Lamprini Karygianni, University Hospital Z&#x000fc;rich, Switzerland; Antoine-Emmanuel Saliba, Helmholtz Association of German Research Centers (HZ), Germany</p></fn><corresp id="c001">*Correspondence: Yan Li, <email>feifeiliyan@163.com</email></corresp><corresp id="c002">Jianxun Sun, <email>jxsun@scu.edu.cn</email></corresp><fn fn-type="other" id="fn002"><p><sup>&#x02020;</sup>These authors have contributed equally to this work</p></fn><fn fn-type="other" id="fn004"><p>This article was submitted to Infectious Diseases, a section of the journal Frontiers in Microbiology</p></fn></author-notes><pub-date pub-type="epub"><day>31</day><month>7</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>31</day><month>7</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>11</volume><elocation-id>1840</elocation-id><history><date date-type="received"><day>28</day><month>3</month><year>2020</year></date><date date-type="accepted"><day>14</day><month>7</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Bao, Zhang, Dong, Zhao, Li and Sun.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Bao, Zhang, Dong, Zhao, Li and Sun</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>The new coronavirus SARS-CoV-2, the cause of COVID-19, has become a public health emergency of global concern. Like the SARS and influenza pandemics, there have been a large number of cases coinfected with other viruses, fungi, and bacteria, some of which originate from the oral cavity. <italic>Capnocytophaga</italic>, <italic>Veillonella</italic>, and other oral opportunistic pathogens were found in the BALF of the COVID-19 patients by mNGS. Risk factors such as poor oral hygiene, cough, increased inhalation under normal or abnormal conditions, and mechanical ventilation provide a pathway for oral microorganisms to enter the lower respiratory tract and thus cause respiratory disease. Lung hypoxia, typical symptoms of COVID-19, would favor the growth of anaerobes and facultative anaerobes originating from the oral microbiota. SARS-CoV-2 may aggravate lung disease by interacting with the lung or oral microbiota via mechanisms involving changes in cytokines, T cell responses, and the effects of host conditions such as aging and the oral microbiome changes due to systemic diseases. Because the oral microbiome is closely associated with SARS-CoV-2 co-infections in the lungs, effective oral health care measures are necessary to reduce these infections, especially in severe COVID-19 patients. We hope this review will draw attention from both the scientific and clinical communities on the role of the oral microbiome in the current global pandemic.</p></abstract><kwd-group><kwd>oral microbiome</kwd><kwd>SARS-CoV-2</kwd><kwd>influenza</kwd><kwd>microaspiration</kwd><kwd>co-infection</kwd><kwd>oral care</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content></funding-source><award-id rid="cn001">81771085</award-id><award-id rid="cn001">81700036</award-id><award-id rid="cn001">81991502</award-id><award-id rid="cn001">81970944</award-id></award-group></funding-group><counts><fig-count count="1"/><table-count count="1"/><equation-count count="0"/><ref-count count="152"/><page-count count="13"/><word-count count="0"/></counts></article-meta></front><body><sec id="S1"><title>Introduction</title><p>Corona Virus Disease 2019 (COVID-19) caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have spread worldwide (<xref rid="B149" ref-type="bibr">Zhu N. et al., 2020</xref>). As of June 19, 2020, World Health Organization (WHO) reported over 8.3 million total confirmed cases and 450 thousand deaths of COVID-19 all over the world (<xref rid="B131" ref-type="bibr">World Health Organization, 2020</xref>), making it a severe threat to public health. However, the mechanism involving virus proliferation and how the virus interacts with other microorganisms in the lung is still unclear. The development of metagenomic next-generation sequencing (mNGS) technique allows for the investigation of novel or mixed pathogens (i.e., RNA viruses, DNA viruses, bacteria, and fungi) directly from original clinical samples (<xref rid="B111" ref-type="bibr">Shi et al., 2018</xref>), especially those from emergent patients. Metatranscriptome sequencing for the bronchoalveolar lavage fluid (BALF) of 8 COVID-19 patients revealed the presence of elevated levels of oral and upper respiratory commensal bacteria (<xref rid="B110" ref-type="bibr">Shen et al., 2020</xref>). It is well-known that an oral-lung aspiration axis is a key factor leading to many infectious diseases (<xref rid="B80" ref-type="bibr">Mammen et al., 2020</xref>).</p><p>The oral cavity houses the second largest microbiota in the human body and can include bacteria, fungi, viruses, and archaea (<xref rid="B28" ref-type="bibr">Dewhirst et al., 2010</xref>). As a large number of opportunistic pathogens and a variety of antibiotic resistance genes have been detected in the calculus of ancient human remains by analyzing the microbial DNA contained within them, it is supposed that the oral cavity, an ecological reservoir for potential pathogens, is involved in local and systemic diseases (<xref rid="B127" ref-type="bibr">Warinner et al., 2014</xref>). The main bacterial genera, by abundance, present within the normal oral cavity include <italic>Neisseria</italic>, <italic>Corynebacterium</italic>, <italic>Leptotrichia</italic>, <italic>Streptococcus</italic>, <italic>Prevotella</italic>, <italic>Veillonella</italic>, <italic>Fusobacterium</italic>, and <italic>Capnocytophaga</italic> (<xref rid="B73" ref-type="bibr">Li et al., 2014</xref>). The dominant genera of healthy lungs include <italic>Streptococcus</italic>, <italic>Fusobacterium</italic>, <italic>Pseudomonas</italic>, <italic>Veillonella</italic>, <italic>Prevotella</italic>, and <italic>Capnocytophaga</italic> (<xref rid="B12" ref-type="bibr">Beck et al., 2015</xref>; <xref rid="B29" ref-type="bibr">Dickson and Huffnagle, 2015</xref>; <xref rid="B134" ref-type="bibr">Wypych et al., 2019</xref>; <xref rid="B110" ref-type="bibr">Shen et al., 2020</xref>), colonizing the oral cavity as well. Microbiota that have migrated from the oral cavity, rather than those from the nasal flora, is likely to be an important source of microbiota in the lungs under normal conditions (<xref rid="B11" ref-type="bibr">Bassis et al., 2015</xref>). Multiple studies have shown that lung microbiota are more similar to those in the oropharynx, than those in the air, nasopharynx or lower digestive tract (<xref rid="B104" ref-type="bibr">Segal et al., 2013</xref>; <xref rid="B121" ref-type="bibr">Venkataraman et al., 2015</xref>). It was demonstrated that acellular bronchoalveolar lavage samples from half of healthy individuals are enriched with oral taxa (<xref rid="B106" ref-type="bibr">Segal et al., 2016</xref>), providing further evidence for the relationship between the microbial community in the lungs and the oral cavity. Additionally, many human bacterial pathogens can also colonize the respiratory tract of healthy individuals asymptomatically (<xref rid="B6" ref-type="bibr">Arora et al., 2015</xref>). The oral microbiome could be a driving force for bacteriome shifts by regulating mucosal immunity, which directly or indirectly affects pathogenicity (<xref rid="B74" ref-type="bibr">Li et al., 2019</xref>).</p><p>SARS-CoV-2 is a single-stranded RNA &#x003b2;-coronavirus and a member of the subgenus Sarbecovirus (beta-CoV lineage B). It is the seventh member of the <italic>Coronaviridae</italic> known to infect humans so far, two of which, SARS-CoV and MERS-CoV, caused global health threats previously (<xref rid="B40" ref-type="bibr">Guarner, 2020</xref>; <xref rid="B69" ref-type="bibr">Letko et al., 2020</xref>). Genome sequencing demonstrated that SARS-CoV-2 shares 79.5% sequence identity with SARS-CoV (<xref rid="B148" ref-type="bibr">Zhou et al., 2020</xref>), which is composed of single-stranded RNA with possible variations like those of the influenza virus. Other research has indicated a higher viral load in the nose than in the throat, viral nucleic acid change model in the patients infected with SARS-CoV-2 were similar to those in the patients with influenza viruses but different from that of SARS-CoV (<xref rid="B125" ref-type="bibr">Wang et al., 2020</xref>).</p><p>Following several influenza virus pandemics and the maturation of genome sequencing in recent years, studies on the co-infections caused by viruses, bacteria, or fungi have increased. Epidemiological data indicated that bacterial complications further increased morbidity and mortality of influenza infection. The &#x0201c;Spanish flu&#x0201d; of 1918 was the most severe influenza pandemic on record, 95% of the mortality due to bacterial infection (<xref rid="B86" ref-type="bibr">Morens et al., 2008</xref>). During the 2009 influenza pandemic, almost one in four patients presented bacterial complications (<xref rid="B79" ref-type="bibr">MacIntyre et al., 2018</xref>). The frequency of influenza and bacterial co-infection ranged from 2% to 65%. Among them, <italic>Streptococcus pneumoniae</italic> and <italic>Staphylococcus aureus</italic>, which accounted for 35% and 28% of infections (<xref rid="B60" ref-type="bibr">Klein et al., 2016</xref>). In addition, bacterial co-infection occurred in 7% of hospitalized COVID-19 patients. Compared with patients in mixed wards/intensive care unit (ICU) settings, ICU patients have a higher proportion of bacterial infections (<xref rid="B67" ref-type="bibr">Lansbury et al., 2020</xref>). These studies suggested that keen vigilance should be maintained against infections derived from the oral microbiome during infection by respiratory viruses and have uncovered risk factors such as increased inhalation, poor oral hygiene, and viral infection are related to the occurrence of respiratory infection (<xref rid="B91" ref-type="bibr">Pace and McCullough, 2010</xref>; <xref rid="B63" ref-type="bibr">Krone et al., 2014</xref>; <xref rid="B50" ref-type="bibr">Iki et al., 2016</xref>). The mechanisms by which the oral microbiome can influence respiratory disease is complicated and multifactorial, simultaneously affected by environmental, host, and microbial factors (<xref rid="B136" ref-type="bibr">Xu et al., 2018</xref>).</p><p>Considering the presented discussion, microbial co-infection increases the risk of disease severity in humans, while the mechanism is still unclear. Therefore, it is crucial to study the source and mechanism of co-infectious pathogens. In this review, we described the pathogens, i.e., viruses, bacteria and fungi, involved in co-infections in COVID-19 patients and summarized previous studies on the SARS-CoV and the influenza virus. We also discussed the possible disruptive factors contributing to co-infection and emphasized the potential role of the oral microbiome in the prognosis of COVID-19 patients. Understanding that the microbiome correlates with co-infections or affects the mucosal immune system helps to better predict the clinical outcomes and prevent complications.</p></sec><sec id="S2"><title>Co-Infection of Oral Microbiome and Sars-CoV-2 in the Lungs</title><p>It&#x02019;s reported that 1450/2010 (72%) of COVID-19 patients received antimicrobial therapy (<xref rid="B99" ref-type="bibr">Rawson et al., 2020</xref>). The prevention and treatment of bacterial and fungal co-infections by antimicrobial prescribing in hospitalized patients with COVID-19 is necessary (<xref rid="B99" ref-type="bibr">Rawson et al., 2020</xref>; <xref rid="B122" ref-type="bibr">Verweij et al., 2020</xref>). There have been some reports on the microorganisms associated with infection, but the pathogenesis and effects are not fully understood. <italic>Capnocytophaga</italic>, <italic>Veillonella</italic>, and other oral opportunists have been found in the BALF of the COVID-19 patients by mNGS (<xref rid="B133" ref-type="bibr">Wu et al., 2020</xref>), indicating the oral cavity is likely to be a natural reservoir for pathogens inducing those found in COVID-19 patients with co-infections. Metagenomic sequencing has found that the nasopharyngeal bacterial population of COVID-19 patients varied with the length of viral infection. For example, <italic>Fusobacterium periodonticum</italic> significantly decreased 3 days after infection (<xref rid="B85" ref-type="bibr">Moore et al., 2020</xref>). As shown in the gut microbiota of patients with COVID-19 (<xref rid="B152" ref-type="bibr">Zuo et al., 2020</xref>), specific intestinal microbes that can downregulate the expression of ACE2 correlated inversely with SARS-CoV-2 load. Whether <italic>Fusobacterium periodonticum</italic> has the same function, further research should be done.</p><sec id="S2.SS1"><title>The Mixed Infections in COVID-19</title><p>The majority of COVID-19 patients present a mild course, common symptoms including low fever, fatigue, and dry cough, while severe cases always present dyspnea within a week from the onset of symptoms, with rapid deterioration into serious complications, such as acute respiratory distress syndrome (ARDS), multiple organ failure, etc (<xref rid="B107" ref-type="bibr">Sharma et al., 2020</xref>). It is also notable that in some patients with no symptoms or negative RT-PCR results that chest computed tomographic (CT) scans revealed viral pneumonia-like lesions in the lungs, such as bilateral patchy shadows or ground glass opacity, and even lung consolidation, but the frequency is unknown (<xref rid="B125" ref-type="bibr">Wang et al., 2020</xref>; <xref rid="B138" ref-type="bibr">Yan et al., 2020</xref>).</p><p>During a multi-center study in Eastern China (<xref rid="B2" ref-type="bibr">Ai et al., 2020</xref>), nasopharyngeal swab samples were collected for total RNA extraction, followed by multiplex PCR and mNGS analysis. According to the results, 11 of 20 co-infections were identified in laboratory-confirmed COVID-19 cases and included regular respiratory viruses, fungi and bacteria. The most common pathogens detected were <italic>Acinetobacter baumannii</italic>, <italic>Klebsiella pneumoniae</italic>, <italic>Aspergillus flavus</italic>, <italic>Candida glabrata</italic>, and <italic>Candida albicans</italic>. In addition, 5 co-infection cases were found coinfected with a virus, including rhinovirus/enterovirus, H3N2, influenza B and respiratory syncytial virus, suggesting that virus co-infection were not uncommon in winter pneumonia patients. The sequencing revealed that <italic>Leptotrichia buccalis</italic>, <italic>Veillonella parvula</italic>, <italic>Capnocytophaga gingivalis</italic>, and <italic>Prevotella melaninogenica</italic> were overrepresented in the BALF of a COVID-19 patient (<xref rid="B133" ref-type="bibr">Wu et al., 2020</xref>). In another study (<xref rid="B101" ref-type="bibr">Ren et al., 2020</xref>), nucleic acid from the BALF of 5 hospitalized patients was extracted for deep sequencing. Those results showed that apart from SARS-CoVs, some bacterial pathogens could also be detected, including <italic>Acinetobacter</italic>, <italic>Pseudomonas</italic>, <italic>Escherichia</italic>, <italic>Streptococcus</italic>, and <italic>Lactococcus</italic>. <xref rid="B17" ref-type="bibr">Chen L. et al. (2020)</xref> reported that <italic>Capnocytophaga</italic> and <italic>Veillonella</italic> were found in the BALF of COVID-19 patients by mNGS. A recent study revealed coinfection with <italic>Moraxella catarrhalis</italic> in laboratory-proven cases of SARS-CoV-2, and quantified increased bacterial burden in some patients over others (<xref rid="B95" ref-type="bibr">Peddu et al., 2020</xref>). Most of above mentioned microbiota can be found in human oral cavity (<xref rid="B28" ref-type="bibr">Dewhirst et al., 2010</xref>), with the elevated level of oral commensal bacteria were found from the BALF of COVID-19 patients (<xref rid="B110" ref-type="bibr">Shen et al., 2020</xref>), it&#x02019;s worth noting the co-infection occurs between oral microbiota and SARS-CoV-2 in the patients&#x02019; lungs.</p><p>SARS-CoV-2 mainly infect alveolar epithelial type II (AE2) cells (<xref rid="B146" ref-type="bibr">Zhao et al., 2020</xref>), the receptor for SARS-CoV-2, human angiotensin-converting enzyme 2 (ACE2), is also expressed in 0.52% of oral cells, of which 95.86% is expressed in tongue epithelial cells (<xref rid="B135" ref-type="bibr">Xu H. et al., 2020</xref>). This new evidence reveals that SARS-CoV-2 might interact with members of the oral microbiome in either the lungs or the oral cavity.</p></sec><sec id="S2.SS2"><title>The Bacterial Complications in Other Respiratory Viral Infections</title><p>In fact, bacteria are known to participate in interactions between host cells and viruses. Although bacteria are typically secondary invaders during influenza infections, they express virulence factors that promote viral pathogenesis. As a result, viral load increases and clearance rates decline (<xref rid="B83" ref-type="bibr">McCullers, 2014</xref>). Reviewing viral epidemics over the last two decades, such as the outbreaks of Severe Acute Respiratory Syndrome (SARS) in 2003 and H1N1 influenza in 2009, we found that the majority of deaths were caused by bacterial complications (<xref rid="B126" ref-type="bibr">Wang et al., 2003</xref>; <xref rid="B147" ref-type="bibr">Zheng et al., 2003</xref>; <xref rid="B72" ref-type="bibr">Li et al., 2005</xref>; <xref rid="B79" ref-type="bibr">MacIntyre et al., 2018</xref>). Long-term bed rest, mechanical ventilation, and glucocorticoid therapy are all risk factors for opportunistic infection. Long-term bed rest people cannot cough as easily or as well, which allows pooled mucus to stagnate and reduces the clearance of potentially pathogenic material and irritants (<xref rid="B61" ref-type="bibr">Knight et al., 2009</xref>).</p><p>Studies on confirmed SARS cases showed that co-infection was one of the major complications, especially in those who underwent extended hospitalization and long-term mechanical ventilation. Some conditional pathogens such as <italic>Enterococcus faecalis</italic>, <italic>Klebsiella pneumonia</italic>, <italic>Acinetobacter baumannii</italic>, <italic>Stenotrophomonas maltophilia</italic>, and <italic>Candida albicans</italic> could come from hospital environment, nosocomial infection, but the majority inhabit the oral cavity (<xref rid="B147" ref-type="bibr">Zheng et al., 2003</xref>; <xref rid="B72" ref-type="bibr">Li et al., 2005</xref>). Even though NGS technology was just coming into use during the SARS outbreak, it was difficult to identify the total microbial composition in clinical samples, therefore microorganisms from clinical specimens, such as blood, urine, sputum and BALF, of SARS patients were collected with conventional culture, and then underwent sensitivity testing and drug resistance testing (<xref rid="B144" ref-type="bibr">Zhang et al., 2004</xref>; <xref rid="B72" ref-type="bibr">Li et al., 2005</xref>). Some pathogens, such as anaerobes, cannot be easily cultured, making accurate diagnosis and treatment of infections challenging.</p><p>Influenza is the most common type of acute respiratory infection (<xref rid="B42" ref-type="bibr">Hanada et al., 2018</xref>) and bacterial complications were an important complication of the 2009 influenza pandemic (<xref rid="B79" ref-type="bibr">MacIntyre et al., 2018</xref>). Similar to SARS, conditional pathogens were the most common infectious microbes (<xref rid="B87" ref-type="bibr">Muscedere et al., 2013</xref>; <xref rid="B79" ref-type="bibr">MacIntyre et al., 2018</xref>). Conditional pathogenic bacteria, such as <italic>Legionella pneumophila</italic> (<xref rid="B102" ref-type="bibr">Rizzo et al., 2010</xref>), <italic>Neisseria meningitidis, Moraxella catarrhalis</italic> (<xref rid="B26" ref-type="bibr">Dela Cruz and Wunderink, 2017</xref>), from the upper respiratory tract are also associated with influenza co-infection. Furthermore, comprehensive detection of potential pathogens was performed using next-generation DNA sequencing of total RNAs extracted from an autopsied lung of a patient died of A/H1N1/2009. <italic>Streptococcus pneumoniae</italic> and <italic>Porphyromonas gingivalis</italic> were detected, though in small quantities. <italic>P. gingivalis</italic> is the most important periodontitis pathogen, while <italic>Streptococcus</italic> sp., in general, constitute the main component of oral flora (<xref rid="B65" ref-type="bibr">Kuroda et al., 2010</xref>). All of these indicate a myriad of relationships between viral infection and the oral microbiome.</p></sec><sec id="S2.SS3"><title>How the Oral Microbiome May Cause Lung Infection</title><p>Risk factors such as poor oral hygiene, cough, increased inhalation under normal or abnormal condition, and mechanical ventilation are the main routes by oral microbiota enter the airways. Additionally, lung hypoxia would stimulate the growth of anaerobes and facultative anaerobes derived from oral microbiota. Together, these factors result in respiratory dysbiosis, and thus cause respiratory disease.</p><sec id="S2.SS3.SSS1"><title>Oral Hygiene</title><p>An increasing number of research projects aim to assess oral health and the prevalence of pre-existing oral colonization by respiratory pathogens in the elderly, and to verify whether these factors could influence pneumonia progression. Various types of oral microorganisms can be detected from the lungs due to different risk factors. Periodontal pathogens such as <italic>Treponema denticola, P. gingivalis, Fusobacterium nucleatum, Actinobacillus actinomycetemcomitans</italic> and <italic>Veillonella parvula</italic>, have been detected in the lungs of ICU patients (<xref rid="B64" ref-type="bibr">Kumar, 2017</xref>; <xref rid="B24" ref-type="bibr">de Carvalho Baptista et al., 2018</xref>). The tongue dorsum is one habitat niche of oral microbes, there the dominant microflora are <italic>Prevotella</italic> and <italic>Veillonella</italic>, which are associated with an increased risk of death due to pneumonia in older, frail patients (<xref rid="B7" ref-type="bibr">Asakawa et al., 2018</xref>; <xref rid="B53" ref-type="bibr">Kageyama et al., 2018</xref>). Dental plaques contain pathogens which could aggravate the state of pneumonia (<xref rid="B90" ref-type="bibr">Olsen, 2015</xref>), including <italic>P. gingivalis</italic>, which can synergistically enhance pathogenicity (<xref rid="B84" ref-type="bibr">Miller et al., 2018</xref>). Poor oral hygiene habits can lead to the accumulation of many periodontal microorganisms in the oral cavity, and oral dysbiosis can accelerate lung function decline (<xref rid="B115" ref-type="bibr">Takeuchi et al., 2018</xref>; <xref rid="B130" ref-type="bibr">Winning et al., 2019</xref>), which in turn can increase the incidence of pneumonia (<xref rid="B64" ref-type="bibr">Kumar, 2017</xref>). A one-year longitudinal study of 60 dependent elderly showed that the amount of respiratory pathogens colonizing the tongue and calculus, e.g., <italic>P. aeruginosa</italic> and <italic>H. influenzae</italic>, were high risk factors for pneumonia progression, while oral hygiene measures, such as removal of calculus and tongue biofilm, helped to reduce this (<xref rid="B45" ref-type="bibr">Hong et al., 2018</xref>). In conclusion, oral hygiene measures are necessary to protect people who are vulnerable to respiratory infections.</p></sec><sec id="S2.SS3.SSS2"><title>Cough and Inhalation</title><p>Because the dominant bacteria in various ecological niches of the body are different, microaspiration and transcolonization can result in systemic dysbiosis and disorders. Oral microorganisms reach the lower respiratory tract primarily through these mechanisms (<xref rid="B113" ref-type="bibr">Soussan et al., 2019</xref>) in severe patients located in hospitals and sanatoriums, or elderly people with dysphagia. A half-year prospective cohort study (<xref rid="B81" ref-type="bibr">Man et al., 2019</xref>) showed that nasopharyngeal microecological imbalance was caused by transcolonization of oral microbiota, leading to upper respiratory tract infections. It is speculated that aspiration pneumonia is also closely related to oral microorganisms due to the aspiration of oropharyngeal secretions (<xref rid="B41" ref-type="bibr">Hajishengallis, 2015</xref>). The frequency of microaspiration will rise in chronic inflammatory respiratory diseases, therefore it is necessary to pay attention to co-infections caused by oral microorganisms.</p></sec><sec id="S2.SS3.SSS3"><title>Mechanical Ventilation</title><p>Mechanical ventilation is generally used to assist or replace spontaneous breathing, involving two types, invasive ventilation and non-invasive ventilation. The former refers to mechanical ventilation that involves any instrument entering the trachea through the oral cavity, like trachea intubation and ECMO. Non-invasive ventilation, such as face or nasal masks, are generally appropriate for mild illnesses. Ventilator-associated pneumonia (VAP) frequently occurs in patients requiring mechanical ventilation, leading to high mortality, with an incidence from 5% to 67% depending on the population studied and the diagnostic criteria used (<xref rid="B9" ref-type="bibr">Barbier et al., 2013</xref>; <xref rid="B119" ref-type="bibr">Torres et al., 2017</xref>). In the process of orotracheal intubation, bacteria can rapidly migrate from the oral cavity and upper respiratory tract into the lungs (<xref rid="B24" ref-type="bibr">de Carvalho Baptista et al., 2018</xref>). Another risk factor is that ICU mechanical ventilation patients find it difficult to clear oral secretions via swallowing or coughing (<xref rid="B92" ref-type="bibr">Paju and Scannapieco, 2007</xref>). Many studies have reported that the main pathophysiologic mechanism for VAP development is oropharyngeal colonization (<xref rid="B31" ref-type="bibr">Dor&#x000e9; et al., 1996</xref>; <xref rid="B8" ref-type="bibr">Bahrani-Mougeot et al., 2007</xref>). Several members of the oral microbiota (e.g., <italic>Streptococcus oralis, Prevotella salivae</italic>, and <italic>Mycoplasma salivarium</italic>) have previously been detected by 16S rRNA gene analysis in the BALF samples of VAP patients (<xref rid="B8" ref-type="bibr">Bahrani-Mougeot et al., 2007</xref>). Respiratory distress and hypoxemia are the main clinical symptoms in severe COVID-19 patients due to serous exudation and hyaline membrane formation of their alveolar spaces. Oxygen saturation, as measured in their fingers, of less than 93% or as low as 50% have been observed (<xref rid="B88" ref-type="bibr">National Health Commission of the People&#x02019;s Republic of China, 2020</xref>). Therefore, they require high-flow nasal cannula or higher-level oxygen support measures to correct this hypoxemia. The lung hypoxia created in these patients is a suitable environment for the growth of anaerobic bacteria including those from the oral microbiota. Therefore, more attention should be paid to potential infections arising from oral microbiota before, and during, mechanical ventilation.</p></sec></sec></sec><sec id="S3"><title>Interaction Between Oral Microbiome and Virus Infection</title><p>SARS-CoV-2 can be detected from different body fluids and the rate of positive test results vary depending on the sample size, days after illness onset, and severity of illness. According to a study on 213 confirmed COVID-19 patients, viral RNA could be detected in all BALF samples of severe cases, but not from mild cases. Sputum appeared to be a good clinical sample with a high positive rate (74.4&#x0223c;88.9%), followed by nasal swabs (53.6&#x0223c;73.3%) and throat swabs (50&#x0223c; 61.3%). When the onset time was greater than 14 days, the positive rate of BALF, sputum, and nasal swabs showed similar results, and were still much higher than throat swabs (<xref rid="B140" ref-type="bibr">Yang et al., 2020</xref>). The viral load in throat swabs and sputum samples peaked at 5&#x02013;6 days after onset and ranged from 10<sup>4</sup> to 10<sup>7</sup> copies/ml (<xref rid="B93" ref-type="bibr">Pan et al., 2020</xref>). What&#x02019;s more, saliva appeared to be a good clinical specimen in the early stage of the disease, with SARS-CoV-2 detected in the initial saliva of 91.7% (11/12) of patients (<xref rid="B118" ref-type="bibr">To et al., 2020b</xref>), however the sample size was small in that study. Another study (<xref rid="B117" ref-type="bibr">To et al., 2020a</xref>) reported that the viral load of SARS-CoV-2 in posterior oropharyngeal saliva samples was highest during the first week of symptom onset. SARS-CoV-2 show high affinity with ACE2, which are higher in tongue, than in buccal or gingival, tissues (<xref rid="B135" ref-type="bibr">Xu H. et al., 2020</xref>).</p><p>At present, the impact of coronavirus on the oral, lung, and gut microbiomes has not been well-researched. However, we found a study on the changes in gut microbiota of swine infected by porcine epidemic virus (a member of the family <italic>Coronaviridae</italic>). Interestingly, <italic>Fusobacteria</italic>, a typically dominant taxa in the oral cavity, was found to predominate in the infected group (approximately 32%, 0.1% in the normal group) (<xref rid="B62" ref-type="bibr">Koh et al., 2015</xref>). Due to the limited amount of data available to date, we would like to focus on the influenza virus and discuss the relationship between influenza viruses and the oral microbiome. It was found that over-expressed <italic>Prevotella</italic> proteins can promote viral infection. As per the results, <italic>Prevotella</italic> proteins, rather than viral proteins, are involved in increasing clinical severity of COVID-2019, i.e., <italic>Prevotella</italic> plays role in COVID- 2019 outbreak and attention should be paid to understanding disease mechanisms and improving treatment outcomes (<xref rid="B58" ref-type="bibr">Khan and Khan, 2020</xref>).</p><sec id="S3.SS1"><title>Oral Microbes Affect Influenza Viral Neuraminidase Activity</title><p>Influenza viruses rely on neuraminidase (NA) activity to release progeny viruses from infected cells and spread the infection. NA is, therefore, an important target of anti-influenza drugs. It was known that the culture supernatants of NA-producing oral bacteria, like <italic>Streptococcus oralis</italic> and <italic>Streptococcus mitis</italic>, can promote the release of influenza virus and cell-to-cell spread of the infection, and also help to increase viral M1 protein expression levels and activation of cellular ERK. These effects were not observed with culture supernatants of <italic>Streptococcus sanguinis</italic> which cannot produce NA (<xref rid="B54" ref-type="bibr">Kamio et al., 2015</xref>). These findings suggest that an increase in the number of NA-producing oral bacteria could elevate the risk of and exacerbate the influenza infection. Considering the tendency of the virus to accelerate the progression of respiratory disease, it is worth noticing the potential impact of oral microbiota on respiratory viral infections. However, the mechanism of interaction between oral bacteria and respiratory viruses to promote lung infection has not been studied in depth, and further attention is urgently needed in this field.</p></sec><sec id="S3.SS2"><title>Influenza Virus-Drive Oral Microecological Imbalance</title><p>Previous research has shown that viruses can drive changes in both local microbial composition and quantity in the lungs. <xref rid="B70" ref-type="bibr">Leung et al. (2013)</xref> conducted an unbiased high-throughput sequencing method to analyze the oropharyngeal microorganisms of pneumonia patients with or without influenza virus infection, and found that the number of <italic>Pseudomonas</italic> and <italic>Bacillus</italic> in the oropharynx increased significantly after influenza virus infection, whereas the number of <italic>Prevotella, Veillonella</italic>, and <italic>Neisseria</italic> decreased significantly. A clinical study (<xref rid="B78" ref-type="bibr">Lu et al., 2017</xref>) showed a large number of <italic>Streptococcus, Actinomyces</italic> and <italic>Rothia</italic> colonizing the oropharynx of flu patients suffering from bacterial complications. What&#x02019;s more, the imbalance of microbiota was also found in patients infected by SARS-CoV-2, <italic>Fusobacterium periodonticum</italic> significantly decreased in the nasopharynx (<xref rid="B85" ref-type="bibr">Moore et al., 2020</xref>),while in the gut, the proportion of probiotics (like <italic>Bifidobacterium</italic>, <italic>Lactobacillus</italic>, and <italic>Eubacterium</italic>) was significantly reduced, and the proportion of conditioned pathogenic bacteria was significantly increased, such as <italic>Corynebacterium</italic> and <italic>Ruthenibacterium</italic> (<xref rid="B141" ref-type="bibr">Yu et al., 2020</xref>), which could lead to microbial translocation and a second infection.</p></sec><sec id="S3.SS3"><title>Co-infection With <italic>P. gingivalis</italic> and Influenza Virus Increased Significant Apoptosis and Necrosis</title><p>As an opportunistic pathogen, <italic>P. gingivalis</italic> cannot be completely eliminated by host cells. An <italic>in vitro</italic> study suggested that during co-infection of <italic>P. gingivalis</italic> and influenza virus, significant apoptosis and necrosis can be observed in lung epithelial cells within a short timeframe (<xref rid="B22" ref-type="bibr">Connolly et al., 2017</xref>) as the Bcl2/Bax/Caspase3 signaling pathway was activated (<xref rid="B19" ref-type="bibr">Chen et al., 2018</xref>). Cytotoxic products of <italic>P. gingivalis</italic> (e.g., lipopolysaccharide) can induce host cells release of inflammatory cytokines such as TNF-&#x003b1;, IL-1&#x003b2;, and IL-6 (<xref rid="B57" ref-type="bibr">Ke et al., 2016</xref>), which in turn increase NO production leading to lung epithelial cell damage (<xref rid="B3" ref-type="bibr">Alayan et al., 2006</xref>; <xref rid="B132" ref-type="bibr">Wu et al., 2016</xref>; <xref rid="B1" ref-type="bibr">Ahamed et al., 2017</xref>).</p></sec></sec><sec id="S4"><title>Effects of Virus and Oral Microbiome on Host Immunity</title><sec id="S4.SS1"><title>Change of Cytokines</title><p>Like SARS-CoV and MERS-CoV, SARS-CoV-2 can also induce excessive and aberrant non-effective host immune responses that are associated with severe lung pathology, and lead to death (<xref rid="B49" ref-type="bibr">Hui and Zumla, 2019</xref>; <xref rid="B47" ref-type="bibr">Huang et al., 2020</xref>). Most moribund COVID-19 patients are suffering from a cytokine storm (<xref rid="B151" ref-type="bibr">Zumla et al., 2020</xref>), which is manifested by the increased plasma concentrations of IL-2, IL-7, IL-10, G-CSF, CXCL10, CCL2, CCL3, and TNF-&#x003b1; (<xref rid="B49" ref-type="bibr">Hui and Zumla, 2019</xref>; <xref rid="B47" ref-type="bibr">Huang et al., 2020</xref>; <xref rid="B71" ref-type="bibr">Li G. et al., 2020</xref>). It has been confirmed that the cellular immunity and cytokines status are closely related to the state of illness, with high levels of IL-6 and IL-10 levels in severe patients (<xref rid="B124" ref-type="bibr">Wan et al., 2020</xref>). We speculate that changes in cytokines reflect disease status to some extent.</p><p>The presence of oral microbes such as <italic>Streptococcus, Prevotella</italic> and <italic>Porphyromonas</italic> can not only change the microbial composition of the respiratory system, but also promote a series of cytokine responses and affect the immune homeostasis of the lungs. The levels of serum IL-6 and IL-8 were significantly increased in patients with lung dysfunction, and local inflammatory factors spread into systemic circulation (<xref rid="B139" ref-type="bibr">Yang et al., 2018</xref>). Under certain conditions, <italic>Streptococcus gordonii</italic> can attack host fibronectin, and subsequent cytokine production can induce inflammatory responses (<xref rid="B34" ref-type="bibr">Erb-Downward et al., 2011</xref>; <xref rid="B77" ref-type="bibr">Liu et al., 2018</xref>). The cell-wall-anchored protein Staphylococcal surface protein A (SspA), a key factor in regulating the host innate immunity, is an immunostimulatory component of <italic>S. gordonii</italic> that promotes bacterial adhesion, and purified SspA can induce IL-6 and monocyte chemotatic protein-1 production from human lung epithelial cells (<xref rid="B4" ref-type="bibr">Andrian et al., 2012</xref>).</p><p><italic>Prevotella</italic> from microaspiration, can also participate in the immune homeostasis of the respiratory tract (<xref rid="B48" ref-type="bibr">Huffnagle et al., 2017</xref>). Lung inflammation has been associated with enrichment of the lung microbiome with <italic>Prevotella</italic>, this organisms primarily activates toll-like receptor 2 and enhance the expression of inflammatory cytokines, including IL-23 and IL-1 (<xref rid="B104" ref-type="bibr">Segal et al., 2013</xref>, <xref rid="B106" ref-type="bibr">2016</xref>). <italic>In vitro</italic> experiments have shown that <italic>Prevotella</italic> can stimulate the production of IL-8, IL-6, and CCL20 in lung epithelial cells, which promotes mucosal Th17 immune response and neutrophil recruitment (<xref rid="B68" ref-type="bibr">Larsen, 2017</xref>).</p><p>Additional research has shown that <italic>Porphyromonas</italic> is likely to affect the immune response as well. Animal experiments (<xref rid="B13" ref-type="bibr">Benedyk et al., 2016</xref>) suggested that <italic>P. gingivalis</italic> can produce Gingipain, which then affect the innate immune response and promote chronic inflammation. Pathological manifestations such as intrapulmonary hemorrhage, necrosis, and neutrophil infiltration occur after infection with <italic>P. gingivalis</italic>. Lung tissue damage is associated with systemic inflammatory response, manifested by elevated levels of TNF, IL-6, IL-17, and C-reactive protein, and these pathological lesions are significantly dependent on the activity of <italic>P. gingivalis</italic>. Besides colonizing the lungs themselves, DNA from oral microbes can be transmited from the gingival tissue to the pulmonary vasculature (<xref rid="B21" ref-type="bibr">Chukkapalli et al., 2018</xref>), this might be a form of distant dissemination causing lung diseases.</p></sec><sec id="S4.SS2"><title>T Cell Responses to Infections</title><p>T cells are a type of lymphocyte which reside in the lungs and play a key role in protecting against chronic inflammation. Both the regulatory T cells (T-regs) and T helper cells (Th cells) are important defenders in the immune system. Previous research has shown that a large number of anaerobic bacteria originating from the oral cavity are present in the lungs of pulmonary tuberculosis patients, and bacterial metabolites (short-chain fatty acids) were associated with both the oral anaerobic bacterial load (e.g., <italic>Prevotella</italic>) and T-regs response (<xref rid="B105" ref-type="bibr">Segal et al., 2017</xref>).</p><p>A study including 1,099 patients with laboratory-confirmed COVID-19 found that the peripheral blood lymphocyte count in severe patients was 95.5% (147/154), which was significantly higher than that of mild cases (<xref rid="B39" ref-type="bibr">Guan et al., 2020b</xref>). It confirmed that the cellular immunity is closely related to the state of illness. In severe patients, CD4<sup>+</sup> T and CD8<sup>+</sup> T levels presented as low, indicating that T cell subsets can be used as one of the bases to predict the transition from mild to severe (<xref rid="B124" ref-type="bibr">Wan et al., 2020</xref>). Based on anatomic reports (<xref rid="B137" ref-type="bibr">Xu Z. et al., 2020</xref>), found that both the peripheral CD4<sup>+</sup> T and CD8<sup>+</sup> T counts of the COVID-19 patients were significantly reduced, but hyperactivated. Additionally, there was an increase in highly pro-inflammatory CCR6<sup>+</sup> Th17 in CD4<sup>+</sup> T cells and a high concentration of cytotoxic granules in CD8<sup>+</sup> T cells. These results imply that hyperactivation of T cells, manifesting as the increase of Th17 and high cytotoxicity of CD8<sup>+</sup> T cells, led to the severe immune injury of the patient to some extent.</p></sec><sec id="S4.SS3"><title>The Host Factors</title><p>SARS-CoV-2 is more likely to affect middle-aged and elderly people, especially those with comorbidities, as a result of the weaker immune functions of these patients (<xref rid="B18" ref-type="bibr">Chen N. et al., 2020</xref>). About 1/4&#x0223c;1/2 patients infected by SARS-CoV-2 had chronic comorbidities, and the prognosis was strongly associated with the presence and number of comorbidities (<xref rid="B18" ref-type="bibr">Chen N. et al., 2020</xref>; <xref rid="B38" ref-type="bibr">Guan et al., 2020a</xref>). Malignancy and chronic obstructive pulmonary disease (COPD) appeared to be the main risk factors leading to poorer clinical outcomes, followed by diabetes and hypertension, according to a retrospective study of 1099 COVID-19 cases (<xref rid="B38" ref-type="bibr">Guan et al., 2020a</xref>). Therefore, immune disorders and long-term chronic inflammatory stimulation are likely to be key drivers to poor prognosis, however more mechanism studies are needed to confirm this.</p><sec id="S4.SS3.SSS1"><title>Aging</title><p>Just like other chronic inflammatory conditions, it is crucial to bear in mind that the elderly, though perhaps seemingly healthy, might respond differently to infectious and inflammatory factors. Apart from the increased risk of severe disease, recovery could also be slower and poor, thus increasing the possibility of recrudescence or aggravation as time passes (<xref rid="B15" ref-type="bibr">Boe et al., 2017</xref>). As human beings age, the niche that <italic>Streptococcus pneumonia (S. pneumoniae)</italic> inhabit might change, resulting in a weakening of microbiome resiliency. This is related to the result of the degeneration of the immune system or a low-grade chronic inflammation (<xref rid="B63" ref-type="bibr">Krone et al., 2014</xref>). The phenomenon of decreased microbial diversity, in conjunction with the presence in the oral cavity of various groups of anaerobic commensals negatively related to the overgrowth of potential lung infection pathogens, was also observed among adults (<xref rid="B25" ref-type="bibr">de Steenhuijsen Piters et al., 2016</xref>). This not only suggest that these anaerobic commensals play an important role in the level of resilience against pathogen overgrowth and disease, but also emphasizes that the chronic inflammatory process contributes to the changes in microbiota composition, potentially making it harder to intervene.</p></sec><sec id="S4.SS3.SSS2"><title>Systemic Diseases Alter Composition and Diversity of the Oral Microbiome</title><p>Compared with healthy individuals, those with chronic diseases have a certain degree of microecological disorder. Here, we will review several comorbidities closely related to COVID-19 as examples to illustrate that changes in composition, quantity, and colonization sites may have potential effects on prognosis. Mounting evidence suggests that oral streptococci can be detected from the lungs of COPD patients (<xref rid="B97" ref-type="bibr">Pragman et al., 2018</xref>) with increased levels of <italic>P. gingivalis</italic> detected in the subgingival plaque (<xref rid="B116" ref-type="bibr">Tan et al., 2019</xref>). The oral microbiota of cancer patients has also been found to be significantly altered. <italic>Veillonella</italic>, <italic>Streptococcus</italic>, <italic>Rothia</italic> and <italic>Aggregatibacter</italic> were dramatically increased in non-small cell lung cancer patients (<xref rid="B145" ref-type="bibr">Zhang W. et al., 2019</xref>) and, except for <italic>Prevotella</italic>, several common oral genera (i.e., <italic>Haemophilus, Neisseria</italic> and <italic>Streptococcus</italic>) decreased in individuals with colitis-associated cancer (<xref rid="B35" ref-type="bibr">Flemer et al., 2018</xref>). Moreover, it has been reported that the diversity of oral microbiota in patients with diabetes decreases significantly, and is associated with an increase in the pathogenic content of the hyperglycemic microbiota (<xref rid="B103" ref-type="bibr">Saeb et al., 2019</xref>), such as <italic>Capnocytophaga, Porphyromonas</italic>, and <italic>Pseudomonas</italic> (<xref rid="B37" ref-type="bibr">Graves et al., 2019</xref>).</p></sec></sec></sec><sec id="S5"><title>Oral Care Interventions for Patients</title><p>Once infected by a virus such as SARS-CoV or SARS-CoV-2, patients are vulnerable to dyspnea, hypoxemia, and even acute respiratory distress syndrome (ARDS), and thus mechanical ventilation becomes a common life-saving intervention. Given the fact that oral microbiota is prone to entering the lower respiratory tract due to increased aspiration and the presence of mechanical ventilation, the prevalence of fatal VAP may increase. However, current guidelines for the management of COVID-19 scarcely emphasize oral care. As discussed above, poor oral hygiene can lead to a large accumulation of pathogens in the oral cavity and immune disorders caused by viral infection can promote additional bacterial/fungal infections, hence increase the risk of secondary pneumonia. Therefore, it is necessary for the clinician to strengthen oral hygiene care for COVID-19 patients.</p><p>Povidone iodine (PV-I, 0.23&#x0223c;1%), cetylpyridinium chloride (CPC, 0.05&#x0223c;0.10%), and hydrogen peroxide (0.5&#x0223c;1.5%) all effectively reduce the number of oral microbiota (<xref rid="B5" ref-type="bibr">Ardizzoni et al., 2018</xref>; <xref rid="B33" ref-type="bibr">Eggers et al., 2018</xref>; <xref rid="B76" ref-type="bibr">Li and Meng, 2020</xref>). Studies have also shown that SARS-CoV, MERS-CoV, and influenza virus A (H1N1) can be efficiently inactivated by these compounds within 1 min (<xref rid="B56" ref-type="bibr">Kariwa et al., 2006</xref>; <xref rid="B32" ref-type="bibr">Eggers et al., 2015</xref>, <xref rid="B33" ref-type="bibr">2018</xref>; <xref rid="B55" ref-type="bibr">Kampf et al., 2020</xref>; <xref rid="B76" ref-type="bibr">Li and Meng, 2020</xref>). Mouthwash containing chlorhexidine (CHX, 0.02%) or CPC have the ability to impair both the biofilm formation of <italic>viridans streptococci</italic> and the adhesion, proinflammatory effects, and immune escape abilities of <italic>Candida albicans</italic> (<xref rid="B5" ref-type="bibr">Ardizzoni et al., 2018</xref>). In addition, 0.05&#x0223c;0.1% CPC showed potent, rapid activity against MERS-CoV (<xref rid="B108" ref-type="bibr">Shen et al., 2019</xref>) and influenza viruses (<xref rid="B96" ref-type="bibr">Popkin et al., 2017</xref>), however it&#x02019;s activity against SARS-CoV-2 is currently unknown. Since SARS-CoV-2 is vulnerable to oxidation, antiseptic mouthwash or gel containing broad spectrum oxidative agents, such as hydrogen peroxide or PV-I, is recommended to reduce the oral microbiota and potentially SARS-CoV-2 as well. 0.02% of CHX is ineffective against coronaviruses as a surface disinfectant, it works as good as 7.5% povidone-iodine or 70% ethyl alcohol when the concentration was increased to 0.05% (<xref rid="B20" ref-type="bibr">Chin et al., 2020</xref>) (<xref rid="T1" ref-type="table">Table 1</xref>).</p><table-wrap id="T1" position="float"><label>TABLE 1</label><caption><p>Characteristics of four common components of mouth rinses.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left" rowspan="1" colspan="1">Mouth rinses</td><td valign="top" align="left" rowspan="1" colspan="1">Characteristics</td><td valign="top" align="left" rowspan="1" colspan="1">Coronaviruses sensitive</td><td valign="top" align="left" rowspan="1" colspan="1">Sources</td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Povidone iodine (PV-I, 0.23&#x0223c;1%)</td><td valign="top" align="left" rowspan="1" colspan="1">Reduce the number of oral microbiota. Inhibit the biofilm formation of <italic>viridans streptococci</italic> and the adhesion, proinflammatory effects, and immune escape abilities of <italic>Candida albicans</italic></td><td valign="top" align="left" rowspan="1" colspan="1">SARS-CoV, MERS-CoV and potentially SARS-CoV-2 sensitive</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B56" ref-type="bibr">Kariwa et al., 2006</xref>; <xref rid="B32" ref-type="bibr">Eggers et al., 2015</xref>, <xref rid="B33" ref-type="bibr">2018</xref>; <xref rid="B5" ref-type="bibr">Ardizzoni et al., 2018</xref>; <xref rid="B55" ref-type="bibr">Kampf et al., 2020</xref>; <xref rid="B76" ref-type="bibr">Li and Meng, 2020</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cetylpyridinium chloride (CPC, 0.05&#x0223c;0.10%)</td><td valign="top" align="left" rowspan="1" colspan="1">Reduce the number of oral microbiota. Inhibit the biofilm formation of <italic>viridans streptococci</italic> and the adhesion, proinflammatory effects, and immune escape abilities of <italic>Candida albicans</italic></td><td valign="top" align="left" rowspan="1" colspan="1">SARS-CoV, MERS-CoV sensitive. SARS-CoV-2 sensitivity is currently unknown</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B56" ref-type="bibr">Kariwa et al., 2006</xref>; <xref rid="B32" ref-type="bibr">Eggers et al., 2015</xref>, <xref rid="B33" ref-type="bibr">2018</xref>; <xref rid="B5" ref-type="bibr">Ardizzoni et al., 2018</xref>; <xref rid="B108" ref-type="bibr">Shen et al., 2019</xref>; <xref rid="B55" ref-type="bibr">Kampf et al., 2020</xref>; <xref rid="B76" ref-type="bibr">Li and Meng, 2020</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>, 0.5&#x0223c;1.5%)</td><td valign="top" align="left" rowspan="1" colspan="1">Reduce the number of oral microbiota</td><td valign="top" align="left" rowspan="1" colspan="1">SARS-CoV, MERS-CoV and potentially SARS-CoV-2 sensitive</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B56" ref-type="bibr">Kariwa et al., 2006</xref>; <xref rid="B32" ref-type="bibr">Eggers et al., 2015</xref>, <xref rid="B33" ref-type="bibr">2018</xref>; <xref rid="B5" ref-type="bibr">Ardizzoni et al., 2018</xref>; <xref rid="B55" ref-type="bibr">Kampf et al., 2020</xref>; <xref rid="B76" ref-type="bibr">Li and Meng, 2020</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Chlorhexidine (CHX, 0.02&#x0223c;0.05%)</td><td valign="top" align="left" rowspan="1" colspan="1">Reduce the number of oral microbiota. Inhibit the biofilm formation of <italic>viridans streptococci</italic> and the adhesion, proinflammatory effects, and immune escape abilities of <italic>Candida albicans</italic></td><td valign="top" align="left" rowspan="1" colspan="1">0.02% CHX is ineffective against coronaviruses while 0.05% is SARS-CoV-2 sensitive</td><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B5" ref-type="bibr">Ardizzoni et al., 2018</xref>; <xref rid="B20" ref-type="bibr">Chin et al., 2020</xref></td></tr></tbody></table></table-wrap><p>Several studies have reported that improving oral hygiene care by either mechanical or chemical control of dental plaque biofilm formation can reduce the number of potential respiratory pathogens and consequently the risk and mortality risk of aspiration pneumonia by as much as 60% (<xref rid="B27" ref-type="bibr">Dennesen et al., 2003</xref>; <xref rid="B120" ref-type="bibr">Tuon et al., 2017</xref>). Oral hygiene care, in these cases, include the use of mouthwash or gels, toothbrush, alone or in combination, together with sputum aspiration and saliva maintenance (<xref rid="B46" ref-type="bibr">Hua et al., 2016</xref>). Specifically, the following practices should be taken: brushing of the teeth, gums, and tongue at least twice a day, moistening the oral mucosa and lips every 2&#x02013;4 h, rinsing the mouth with mouthwash containing 0.5&#x0223c;1.5% hydrogen peroxide, 0.05&#x0223c;0.10% CPC or 0.23&#x0223c;1% PV-I twice a day and wiping with 1.5% hydrogen peroxide.</p></sec><sec id="S6"><title>Research Approaches for Co-Infections</title><p>There are many key unsolved questions in the field of co-infections. A better understanding of the complex relationship between viruses, hosts, and bacteria will help us cope with common manifestations, such as community-acquired pneumonia, and help us prepare for the next severe pandemic. The study of lung organoidsand animal models of co-infection can help us to better study co-infection and push forward the field.</p><sec id="S6.SS1"><title>Better Diagnostics of Co-infections</title><p>A variety of detection methods are designed to analyze the co-infection of new coronavirus and other microorganisms (<xref rid="B143" ref-type="bibr">Zhang et al., 2020</xref>). Fluorescence quantitative PCR (RT-PCR) detection of viral nucleic acid is the main method of identification (<xref rid="B43" ref-type="bibr">Hashemzadeh et al., 2016</xref>; <xref rid="B59" ref-type="bibr">Kim et al., 2016</xref>; <xref rid="B89" ref-type="bibr">Noh et al., 2017</xref>; <xref rid="B142" ref-type="bibr">Zhang H. et al., 2019</xref>). Of course, specific primers based on known bacterial/fungal sequences can be designed to detect co-infected species and multiplex RT-PCR was applied to seven family members for differential diagnosis of 18 types of viruses and 4 types of bacteria (<xref rid="B16" ref-type="bibr">Chan et al., 2020</xref>). Digital loop-mediated DNA amplification (LAMP) based on micro-nanofluidic chip (<xref rid="B36" ref-type="bibr">Gansen et al., 2012</xref>; <xref rid="B100" ref-type="bibr">Rems et al., 2016</xref>) can simultaneously detect several common viruses (<xref rid="B112" ref-type="bibr">Shirato et al., 2018</xref>). By collecting deep expectoration or BALF, mNGS can identify the main pathogen SARS-CoV-2 (<xref rid="B17" ref-type="bibr">Chen L. et al., 2020</xref>; <xref rid="B101" ref-type="bibr">Ren et al., 2020</xref>). It has also a high clinical value for the identification of the combined or secondary bacteria, especially for Critical Care patients with sepsis, immunosuppressive host complicate with severe infection, severe pulmonary infection, etc (<xref rid="B82" ref-type="bibr">McArdle et al., 2018</xref>). Multiple studies sequenced samples of COVID-19 suspected or confirmed patients found the presence of co-infection, such as oral bacteria, fungi, viruses, etc (<xref rid="B16" ref-type="bibr">Chan et al., 2020</xref>; <xref rid="B23" ref-type="bibr">Cox et al., 2020</xref>; <xref rid="B67" ref-type="bibr">Lansbury et al., 2020</xref>; <xref rid="B114" ref-type="bibr">Tadolini et al., 2020</xref>), which may come from the environment or colonize the mouth. As a result, once the doctors quickly and accurately find the main and sub-pathogen. They can develop drug treatment protocols targeting the pathogens and evaluate treatment effectiveness, and adjust treatment means for severe patients as early as possible.</p></sec><sec id="S6.SS2"><title>Lung Organoids</title><p>&#x0201c;Lung organoids&#x0201d; refers to self-assembled structures produced by three-dimensional cultured lung epithelial progenitor cells, with or without mesenchymal support cells (<xref rid="B10" ref-type="bibr">Barkauskas et al., 2017</xref>). Different epithelial cell populations of the adult lung, including basal cells, secretory Club cells and AEC2 cells, as well as human pluripotent stem cells (hPSCs), are the most attractive sources for lung organoids (<xref rid="B10" ref-type="bibr">Barkauskas et al., 2017</xref>). Over the past decade, they have become indispensable tools for basic research and translational research (<xref rid="B94" ref-type="bibr">Paolicelli et al., 2019</xref>). Organoid is a new &#x0201c;secret weapon&#x0201d; that enables precision medicine. Lung organoids could be developed to study the bacterial co-infection in patients with COVID-19.</p><p>Over the past decade, stem cell-derived, three-dimensional, self-organizing organoids have emerged as a new way to simulate respiratory diseases <italic>in vitro</italic> (<xref rid="B75" ref-type="bibr">Li Y. et al., 2020</xref>). With the help of cutting-edge technologies, like the high-throughtput organoid microinjector system (<xref rid="B129" ref-type="bibr">Williamson et al., 2018</xref>), microinjection of microorganisms into the organoid lumen can be realized to facilitate the study of host-microbial interaction in 3D structures (<xref rid="B14" ref-type="bibr">Bertaux-Skeirik et al., 2015</xref>). Nowadays, lung organoids have been used in microbial infection studies to understand the molecular mechanism of epithelial renewal after viral infection (<xref rid="B98" ref-type="bibr">Quantius et al., 2016</xref>), and to study the cytokine profile release when stimulated by <italic>Pseudomonas aeruginosa</italic> (<xref rid="B109" ref-type="bibr">Shen et al., 2017</xref>). The most difficult obstacle to overcome at present is the complete differentiation of hPSCs cultures into specialized lung cell types, especially AEC1 cells and alveolar-like cells. Efforts are needed to explore new classes of stem cells and support cells, quantify using organoid culture, and compare them with known populations to find better seed cells.</p><p>Due to the short-term organoids culture time (several weeks), lung organoids can be applied to studying the pathogenesis and mechanism of viral-bacterial co-infection or making medication guidelines. And a precise diagnostic platform can be developed based on organoids (<xref rid="B66" ref-type="bibr">Lamers et al., 2020</xref>). Furthermore, patient-derived organoids (PDO) has high predictive ability for co-infection drug candidates, and is suitable for high-throughput cultivation, and thus can be used as an effective drug screening platform (<xref rid="B123" ref-type="bibr">Vlachogiannis et al., 2018</xref>). Take full advantage of the powerful genomic editing technology of CRISPR/Cas9, especially to study the role of specific genes in the self-renewal and differentiation of human lung stem cells and the generation of human respiratory disease models. Organoids which can be modified by various genome-editing techniques and thus different genes can be constructed to express human ACE2 protein to study the pathogenesis of co-infection in COVID-19.</p></sec><sec id="S6.SS3"><title>Animal Models of Co-infection</title><p>According to the mouse construction strategies and methods, the current SARS-CoV-2 infected mouse model is divided into three types: (1) Using mouse hepatitis virus (MHV), a murine coronavirus, as model virus to study its genetic and biological mechanisms in mouse (<xref rid="B128" ref-type="bibr">Weiss, 2020</xref>); (2) Employing gene editing technology to knock out mouse genes such as <italic>ace2</italic> and <italic>Tmprss2</italic>, genes related to viral binding and entry, to explore the pathogenicity-related host factors (<xref rid="B51" ref-type="bibr">Iwata-Yoshikawa et al., 2019</xref>; <xref rid="B44" ref-type="bibr">Hoffmann et al., 2020</xref>), or transfer human protein expressing genes (i.e., human <italic>ace2</italic>) into mice to allow a direct infection of SARS-CoV-2 (<xref rid="B52" ref-type="bibr">Jiang et al., 2020</xref>); (3) Infecting mice with wild-type SARS-CoV-2 virus repeatedly to cultivate an adaptive version of the virus (<xref rid="B30" ref-type="bibr">Dinnon et al., 2020</xref>). So as to establish a mouse model of virus infection that can cause a significant clinical phenotype. Based on the establishment of SARS-CoV-2 single infected mouse model, a co-infection model could be explored by following inoculation of other pathogens, given the fact of viral-bacterial situation during COVID-19 pandemic (<xref rid="B150" ref-type="bibr">Zhu X. et al., 2020</xref>).</p></sec></sec><sec id="S7"><title>Conclusion</title><p>In this review, we described the co-infections in viral disease. The mechanism of viral-bacterial lung co-infections during respiratory viral infections and effect of the oral care interventions for patients are shown in <xref ref-type="fig" rid="F1">Figure 1</xref>. During the SARS-CoV-2 global outbreak, numerous cases are coinfected with other pathogens, some of which originate from the oral cavity. Until now, little work had been done on the coronaviruses and oral microbiomes, and much remains for future study. While previous research has linked lung regional immunity with stable state maintenance or imbalance, current research has only preliminarily explored the influence of oral bacteria in the respiratory system, or the influence of oral bacteria-virus interactions on respiratory diseases. The scientific community must help the world to prepare for the next pandemic and thus to avoid massive loss of life. Drawing on the experiences of SARS in 2003 and influenza outbreaks, we recommend that oral hygiene in COVID 19 patients be a concern as co-infection is critical to prognosis.</p><fig id="F1" position="float"><label>FIGURE 1</label><caption><p>Schematic representation outlining the oral-lung-axis mechanism of viral-bacterial lung co-infection during respiratory viral infections and effect of the oral care interventions for patients. Risk factors such as poor oral hygiene, cough, increased inhalation and mechanical ventilation provide a pathway for oral microorganisms to enter the lower respiratory tract and thus cause co-infection to aggravate respiratory disease via mechanisms involving changes in cytokines, T cell responses, and the effects of host conditions such as aging and the oral microbiome changes due to systemic diseases. Improving oral hygiene care by either mechanical or chemical control of dental plaque biofilm formation would reduce the number of potential respiratory pathogens and inhibit droplet-borne virus route through oral cavity, and hence consequently reduce the risk and mortality risk of aspiration pneumonia.</p></caption><graphic xlink:href="fmicb-11-01840-g001"/></fig></sec><sec id="S8"><title>Author Contributions</title><p>LB and CZ contributed to conception, design, and drafting the manuscript. JD and LZ contributed to conception. YL and JS contributed to conception, design, and critically revise the manuscript. All authors gave final approval and agree to be accountable for all aspects of the work.</p></sec><sec id="conf1"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was supported by grants from the National Natural Science Foundation of China (81771085, 81700036, 81991502, and 81970944), Key Projects of Sichuan Provincial Department of Science and Technology (20SYSX0286), and Special Funds for Prevention and Control of COVID-19 of Sichuan University (2020scunCoV10009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahamed</surname><given-names>M.</given-names></name><name><surname>Akhtar</surname><given-names>M. J.</given-names></name><name><surname>Khan</surname><given-names>M. A. M.</given-names></name><name><surname>Alhadlaq</surname><given-names>H. A.</given-names></name><name><surname>Aldalbahi</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Nanocubes of indium oxide induce cytotoxicity and apoptosis through oxidative stress in human lung epithelial cells.</article-title>
<source><italic>Colloids Surf. B Biointerfaces</italic></source>
<volume>156</volume>
<fpage>157</fpage>&#x02013;<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1016/j.colsurfb.2017.05.020</pub-id>
<?supplied-pmid 28527359?><pub-id pub-id-type="pmid">28527359</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ai</surname><given-names>J.-W.</given-names></name><name><surname>Zhang</surname><given-names>H.-C.</given-names></name><name><surname>Xu</surname><given-names>T.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Zhu</surname><given-names>M.</given-names></name><name><surname>Yu</surname><given-names>Y.-Q.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Optimizing diagnostic strategy for novel coronavirus pneumonia, a multi-center study in Eastern China.</article-title>
<source><italic>medRxiv</italic></source> [<comment>Preprint</comment>] <pub-id pub-id-type="doi">10.1101/2020.02.13.20022673</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alayan</surname><given-names>J.</given-names></name><name><surname>Ivanovski</surname><given-names>S.</given-names></name><name><surname>Gemmell</surname><given-names>E.</given-names></name><name><surname>Ford</surname><given-names>P.</given-names></name><name><surname>Hamlet</surname><given-names>S.</given-names></name><name><surname>Farah</surname><given-names>C. S.</given-names></name></person-group> (<year>2006</year>). <article-title>Deficiency of iNOS contributes to Porphyromonas gingivalis-induced tissue damage.</article-title>
<source><italic>Oral Microbiol. Immunol.</italic></source>
<volume>21</volume>
<fpage>360</fpage>&#x02013;<lpage>365</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-302X.2006.00304.x</pub-id>
<?supplied-pmid 17064393?><pub-id pub-id-type="pmid">17064393</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrian</surname><given-names>E.</given-names></name><name><surname>Qi</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Halperin</surname><given-names>S. A.</given-names></name><name><surname>Lee</surname><given-names>S. F.</given-names></name></person-group> (<year>2012</year>). <article-title>Role of surface proteins SspA and SspB of Streptococcus gordonii in innate immunity.</article-title>
<source><italic>Microbiology</italic></source>
<volume>158(Pt 8)</volume>
<fpage>2099</fpage>&#x02013;<lpage>2106</lpage>. <pub-id pub-id-type="doi">10.1099/mic.0.058073-0</pub-id>
<?supplied-pmid 22609749?><pub-id pub-id-type="pmid">22609749</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ardizzoni</surname><given-names>A.</given-names></name><name><surname>Pericolini</surname><given-names>E.</given-names></name><name><surname>Paulone</surname><given-names>S.</given-names></name><name><surname>Orsi</surname><given-names>C. F.</given-names></name><name><surname>Castagnoli</surname><given-names>A.</given-names></name><name><surname>Oliva</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>In vitro effects of commercial mouthwashes on several virulence traits of Candida albicans, viridans streptococci and Enterococcus faecalis colonizing the oral cavity.</article-title>
<source><italic>PLoS One</italic></source>
<volume>13</volume>:<issue>e0207262</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0207262</pub-id>
<?supplied-pmid 30439994?><pub-id pub-id-type="pmid">30439994</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arora</surname><given-names>S. K.</given-names></name><name><surname>Dewan</surname><given-names>P.</given-names></name><name><surname>Gupta</surname><given-names>P.</given-names></name></person-group> (<year>2015</year>). <article-title>Microbiome: paediatricians&#x02019; perspective.</article-title>
<source><italic>Indian J. Med. Res.</italic></source>
<volume>142</volume>
<fpage>515</fpage>&#x02013;<lpage>524</lpage>. <pub-id pub-id-type="doi">10.4103/0971-5916.171275</pub-id>
<?supplied-pmid 26658584?><pub-id pub-id-type="pmid">26658584</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asakawa</surname><given-names>M.</given-names></name><name><surname>Takeshita</surname><given-names>T.</given-names></name><name><surname>Furuta</surname><given-names>M.</given-names></name><name><surname>Kageyama</surname><given-names>S.</given-names></name><name><surname>Takeuchi</surname><given-names>K.</given-names></name><name><surname>Hata</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Tongue microbiota and oral health status in community-dwelling elderly adults.</article-title>
<source><italic>mSphere</italic></source>
<volume>3</volume>:<issue>e00332-18</issue>. <pub-id pub-id-type="doi">10.1128/mSphere.00332-18</pub-id>
<?supplied-pmid 30111628?><pub-id pub-id-type="pmid">30111628</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bahrani-Mougeot</surname><given-names>F. K.</given-names></name><name><surname>Paster</surname><given-names>B. J.</given-names></name><name><surname>Coleman</surname><given-names>S.</given-names></name><name><surname>Barbuto</surname><given-names>S.</given-names></name><name><surname>Brennan</surname><given-names>M. T.</given-names></name><name><surname>Noll</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Molecular analysis of oral and respiratory bacterial species associated with ventilator-associated pneumonia.</article-title>
<source><italic>J. Clin. Microbiol.</italic></source>
<volume>45</volume>
<fpage>1588</fpage>&#x02013;<lpage>1593</lpage>. <pub-id pub-id-type="doi">10.1128/jcm.01963-06</pub-id>
<?supplied-pmid 17301280?><pub-id pub-id-type="pmid">17301280</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbier</surname><given-names>F.</given-names></name><name><surname>Andremont</surname><given-names>A.</given-names></name><name><surname>Wolff</surname><given-names>M.</given-names></name><name><surname>Bouadma</surname><given-names>L.</given-names></name></person-group> (<year>2013</year>). <article-title>Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management.</article-title>
<source><italic>Curr. Opin. Pulmon. Med.</italic></source>
<volume>19</volume>
<fpage>216</fpage>&#x02013;<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1097/mcp.0b013e32835f27be</pub-id>
<?supplied-pmid 23524477?><pub-id pub-id-type="pmid">23524477</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barkauskas</surname><given-names>C. E.</given-names></name><name><surname>Chung</surname><given-names>M.-I.</given-names></name><name><surname>Fioret</surname><given-names>B.</given-names></name><name><surname>Gao</surname><given-names>X.</given-names></name><name><surname>Katsura</surname><given-names>H.</given-names></name><name><surname>Hogan</surname><given-names>B. L. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Lung organoids: current uses and future promise.</article-title>
<source><italic>Development</italic></source>
<volume>144</volume>
<fpage>986</fpage>&#x02013;<lpage>997</lpage>. <pub-id pub-id-type="doi">10.1242/dev.140103</pub-id>
<?supplied-pmid 28292845?><pub-id pub-id-type="pmid">28292845</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassis</surname><given-names>C. M.</given-names></name><name><surname>Erb-Downward</surname><given-names>J. R.</given-names></name><name><surname>Dickson</surname><given-names>R. P.</given-names></name><name><surname>Freeman</surname><given-names>C. M.</given-names></name><name><surname>Schmidt</surname><given-names>T. M.</given-names></name><name><surname>Young</surname><given-names>V. B.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals.</article-title>
<source><italic>mBio</italic></source>
<volume>6</volume>:<issue>e00037-15</issue>. <pub-id pub-id-type="doi">10.1128/mBio.00037-15</pub-id>
<?supplied-pmid 25736890?><pub-id pub-id-type="pmid">25736890</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>J. M.</given-names></name><name><surname>Schloss</surname><given-names>P. D.</given-names></name><name><surname>Venkataraman</surname><given-names>A.</given-names></name><name><surname>Twigg</surname><given-names>H.</given-names><suffix>III</suffix></name><name><surname>Jablonski</surname><given-names>K. A.</given-names></name><name><surname>Bushman</surname><given-names>F. D.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Multicenter comparison of lung and oral microbiomes of HIV-infected and HIV-uninfected individuals.</article-title>
<source><italic>Am. J. Respir. Crit. Care Med.</italic></source>
<volume>192</volume>
<fpage>1335</fpage>&#x02013;<lpage>1344</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.201501-0128OC</pub-id>
<?supplied-pmid 26247840?><pub-id pub-id-type="pmid">26247840</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benedyk</surname><given-names>M.</given-names></name><name><surname>Mydel</surname><given-names>P. M.</given-names></name><name><surname>Delaleu</surname><given-names>N.</given-names></name><name><surname>Plaza</surname><given-names>K.</given-names></name><name><surname>Gawron</surname><given-names>K.</given-names></name><name><surname>Milewska</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Gingipains: critical factors in the development of aspiration pneumonia caused by <italic>Porphyromonas gingivalis</italic>.</article-title>
<source><italic>J. Innate Immun.</italic></source>
<volume>8</volume>
<fpage>185</fpage>&#x02013;<lpage>198</lpage>. <pub-id pub-id-type="doi">10.1159/000441724</pub-id>
<?supplied-pmid 26613585?><pub-id pub-id-type="pmid">26613585</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertaux-Skeirik</surname><given-names>N.</given-names></name><name><surname>Feng</surname><given-names>R.</given-names></name><name><surname>Schumacher</surname><given-names>M. A.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Mahe</surname><given-names>M. M.</given-names></name><name><surname>Engevik</surname><given-names>A. C.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>CD44 plays a functional role in <italic>Helicobacter</italic> pylori-induced epithelial cell proliferation.</article-title>
<source><italic>PLoS Pathog.</italic></source>
<volume>11</volume>:<issue>e1004663</issue>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1004663</pub-id>
<?supplied-pmid 25658601?><pub-id pub-id-type="pmid">25658601</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boe</surname><given-names>D. M.</given-names></name><name><surname>Boule</surname><given-names>L. A.</given-names></name><name><surname>Kovacs</surname><given-names>E. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Innate immune responses in the ageing lung.</article-title>
<source><italic>Clin. Exp. Immunol.</italic></source>
<volume>187</volume>
<fpage>16</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1111/cei.12881</pub-id>
<?supplied-pmid 27711979?><pub-id pub-id-type="pmid">27711979</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>J. F.-W.</given-names></name><name><surname>Yuan</surname><given-names>S.</given-names></name><name><surname>Kok</surname><given-names>K.-H.</given-names></name><name><surname>To</surname><given-names>K. K.-W.</given-names></name><name><surname>Chu</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.</article-title>
<source><italic>Lancet</italic></source>
<volume>395</volume>
<fpage>514</fpage>&#x02013;<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30154-9</pub-id><pub-id pub-id-type="pmid">31986261</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Xu</surname><given-names>K.</given-names></name><name><surname>Ye</surname><given-names>G.</given-names></name><name><surname>Wu</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak.</article-title>
<source><italic>Emerg. Microbes Infect.</italic></source>
<volume>9</volume>
<fpage>313</fpage>&#x02013;<lpage>319</lpage>. <pub-id pub-id-type="doi">10.1080/22221751.2020.1725399</pub-id>
<?supplied-pmid 32020836?><pub-id pub-id-type="pmid">32020836</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>N.</given-names></name><name><surname>Zhou</surname><given-names>M.</given-names></name><name><surname>Dong</surname><given-names>X.</given-names></name><name><surname>Qu</surname><given-names>J.</given-names></name><name><surname>Gong</surname><given-names>F.</given-names></name><name><surname>Han</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.</article-title>
<source><italic>Lancet</italic></source>
<volume>395</volume>
<fpage>507</fpage>&#x02013;<lpage>513</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(20)30211-7</pub-id><pub-id pub-id-type="pmid">32007143</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>R.</given-names></name><name><surname>Yi</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Porphyromonas gingivalis induced inflammatory responses and promoted apoptosis in lung epithelial cells infected with H1N1 via the Bcl2/Bax/Caspase3 signaling pathway.</article-title>
<source><italic>Mol. Med. Rep.</italic></source>
<volume>18</volume>
<fpage>97</fpage>&#x02013;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2018.8983</pub-id><pub-id pub-id-type="pmid">29750299</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chin</surname><given-names>A.</given-names></name><name><surname>Chu</surname><given-names>J.</given-names></name><name><surname>Perera</surname><given-names>M.</given-names></name><name><surname>Hui</surname><given-names>K.</given-names></name><name><surname>Yen</surname><given-names>H.-L.</given-names></name><name><surname>Chan</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Stability of SARS-CoV-2 in different environmental conditions.</article-title>
<source><italic>medRxiv</italic></source> [<comment>Preprint</comment>] <pub-id pub-id-type="doi">10.1101/2020.03.15.20036673</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chukkapalli</surname><given-names>S. S.</given-names></name><name><surname>Ambadapadi</surname><given-names>S.</given-names></name><name><surname>Varkoly</surname><given-names>K.</given-names></name><name><surname>Jiron</surname><given-names>J.</given-names></name><name><surname>Aguirre</surname><given-names>J. I.</given-names></name><name><surname>Bhattacharyya</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Impaired innate immune signaling due to combined Toll-like receptor 2 and 4 deficiency affects both periodontitis and atherosclerosis in response to polybacterial infection.</article-title>
<source><italic>Pathog. Dis.</italic></source>
<volume>76</volume>:<issue>fty076</issue>. <pub-id pub-id-type="doi">10.1093/femspd/fty076</pub-id>
<?supplied-pmid 30351354?><pub-id pub-id-type="pmid">30351354</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Connolly</surname><given-names>E.</given-names></name><name><surname>Millhouse</surname><given-names>E.</given-names></name><name><surname>Doyle</surname><given-names>R.</given-names></name><name><surname>Culshaw</surname><given-names>S.</given-names></name><name><surname>Ramage</surname><given-names>G.</given-names></name><name><surname>Moran</surname><given-names>G. P.</given-names></name></person-group> (<year>2017</year>). <article-title>The Porphyromonas gingivalis hemagglutinins HagB and HagC are major mediators of adhesion and biofilm formation.</article-title>
<source><italic>Mol. Oral Microbiol.</italic></source>
<volume>32</volume>
<fpage>35</fpage>&#x02013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1111/omi.12151</pub-id>
<?supplied-pmid 28051836?><pub-id pub-id-type="pmid">28051836</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>M. J.</given-names></name><name><surname>Loman</surname><given-names>N.</given-names></name><name><surname>Bogaert</surname><given-names>D.</given-names></name><name><surname>O&#x02019;Grady</surname><given-names>J.</given-names></name></person-group> (<year>2020</year>). <article-title>Co-infections: potentially lethal and unexplored in COVID-19.</article-title>
<source><italic>Lancet Microbe</italic></source>
<volume>1</volume>:<issue>e11</issue>
<pub-id pub-id-type="doi">10.1016/S2666-5247(20)30009-4</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Carvalho Baptista</surname><given-names>I. M.</given-names></name><name><surname>Martinho</surname><given-names>F. C.</given-names></name><name><surname>Nascimento</surname><given-names>G. G.</given-names></name><name><surname>da Rocha Santos</surname><given-names>C. E.</given-names></name><name><surname>Prado</surname><given-names>R. F. D.</given-names></name><name><surname>Valera</surname><given-names>M. C.</given-names></name></person-group> (<year>2018</year>). <article-title>Colonization of oropharynx and lower respiratory tract in critical patients: risk of ventilator-associated pneumonia.</article-title>
<source><italic>Arch. Oral Biol.</italic></source>
<volume>85</volume>
<fpage>64</fpage>&#x02013;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1016/j.archoralbio.2017.09.029</pub-id>
<?supplied-pmid 29031240?><pub-id pub-id-type="pmid">29031240</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Steenhuijsen Piters</surname><given-names>W. A.</given-names></name><name><surname>Huijskens</surname><given-names>E. G.</given-names></name><name><surname>Wyllie</surname><given-names>A. L.</given-names></name><name><surname>Biesbroek</surname><given-names>G.</given-names></name><name><surname>van den Bergh</surname><given-names>M. R.</given-names></name><name><surname>Veenhoven</surname><given-names>R. H.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Dysbiosis of upper respiratory tract microbiota in elderly pneumonia patients.</article-title>
<source><italic>ISME J.</italic></source>
<volume>10</volume>
<fpage>97</fpage>&#x02013;<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1038/ismej.2015.99</pub-id>
<?supplied-pmid 26151645?><pub-id pub-id-type="pmid">26151645</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dela Cruz</surname><given-names>C. S.</given-names></name><name><surname>Wunderink</surname><given-names>R. G.</given-names></name></person-group> (<year>2017</year>). <article-title>Respiratory viral and atypical pneumonias.</article-title>
<source><italic>Clin. Chest Med.</italic></source>
<volume>38</volume>
<fpage>xiii</fpage>&#x02013;<lpage>xiv</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccm.2016.12.001</pub-id>
<?supplied-pmid 28159166?><pub-id pub-id-type="pmid">28159166</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dennesen</surname><given-names>P.</given-names></name><name><surname>van der Ven</surname><given-names>A.</given-names></name><name><surname>Vlasveld</surname><given-names>M.</given-names></name><name><surname>Lokker</surname><given-names>L.</given-names></name><name><surname>Ramsay</surname><given-names>G.</given-names></name><name><surname>Kessels</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Inadequate salivary flow and poor oral mucosal status in intubated intensive care unit patients.</article-title>
<source><italic>Crit. Care Med.</italic></source>
<volume>31</volume>
<fpage>781</fpage>&#x02013;<lpage>786</lpage>. <pub-id pub-id-type="doi">10.1097/01.ccm.0000053646.04085.29</pub-id><pub-id pub-id-type="pmid">12626984</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dewhirst</surname><given-names>F. E.</given-names></name><name><surname>Chen</surname><given-names>T.</given-names></name><name><surname>Izard</surname><given-names>J.</given-names></name><name><surname>Paster</surname><given-names>B. J.</given-names></name><name><surname>Tanner</surname><given-names>A. C. R.</given-names></name><name><surname>Yu</surname><given-names>W. H.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>The human oral microbiome.</article-title>
<source><italic>J. Bacteriol.</italic></source>
<volume>192</volume>
<fpage>5002</fpage>&#x02013;<lpage>5017</lpage>. <pub-id pub-id-type="doi">10.1128/jb.00542-10</pub-id>
<?supplied-pmid 20656903?><pub-id pub-id-type="pmid">20656903</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dickson</surname><given-names>R. P.</given-names></name><name><surname>Huffnagle</surname><given-names>G. B.</given-names></name></person-group> (<year>2015</year>). <article-title>The lung microbiome: new principles for respiratory bacteriology in health and disease.</article-title>
<source><italic>PLoS Pathog.</italic></source>
<volume>11</volume>:<issue>e1004923</issue>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1004923</pub-id>
<?supplied-pmid 26158874?><pub-id pub-id-type="pmid">26158874</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinnon</surname><given-names>K. H.</given-names></name><name><surname>Leist</surname><given-names>S. R.</given-names></name><name><surname>Sch&#x000e4;fer</surname><given-names>A.</given-names></name><name><surname>Edwards</surname><given-names>C. E.</given-names></name><name><surname>Martinez</surname><given-names>D. R.</given-names></name><name><surname>Montgomery</surname><given-names>S. A.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasures.</article-title>
<source><italic>bioRxiv</italic></source> [<comment>Preprint</comment>] <pub-id pub-id-type="doi">10.1101/2020.05.06.081497</pub-id>
<?supplied-pmid 32511406?><pub-id pub-id-type="pmid">32511406</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dor&#x000e9;</surname><given-names>P.</given-names></name><name><surname>Robert</surname><given-names>R.</given-names></name><name><surname>Grollier</surname><given-names>G.</given-names></name><name><surname>Rouffineau</surname><given-names>J.</given-names></name><name><surname>Lanquetot</surname><given-names>H.</given-names></name><name><surname>Charri&#x000e8;re</surname><given-names>J.-M.</given-names></name><etal/></person-group> (<year>1996</year>). <article-title>Incidence of anaerobes in ventilator-associated pneumonia with use of a protected specimen brush.</article-title>
<source><italic>Am. J. Respir. Crit. Care Med.</italic></source>
<volume>153</volume>
<fpage>1292</fpage>&#x02013;<lpage>1298</lpage>. <pub-id pub-id-type="doi">10.1164/ajrccm.153.4.8616556</pub-id>
<?supplied-pmid 8616556?><pub-id pub-id-type="pmid">8616556</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eggers</surname><given-names>M.</given-names></name><name><surname>Eickmann</surname><given-names>M.</given-names></name><name><surname>Zorn</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Rapid and effective virucidal activity of povidone-iodine products against middle east respiratory syndrome coronavirus (MERS-CoV) and modified vaccinia virus ankara (MVA).</article-title>
<source><italic>Infect. Dis. Ther.</italic></source>
<volume>4</volume>
<fpage>491</fpage>&#x02013;<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1007/s40121-015-0091-9</pub-id>
<?supplied-pmid 26416214?><pub-id pub-id-type="pmid">26416214</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eggers</surname><given-names>M.</given-names></name><name><surname>Koburger-Janssen</surname><given-names>T.</given-names></name><name><surname>Eickmann</surname><given-names>M.</given-names></name><name><surname>Zorn</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>In vitro bactericidal and virucidal efficacy of povidone-iodine gargle/mouthwash against respiratory and oral tract pathogens.</article-title>
<source><italic>Infect. Dis. Ther.</italic></source>
<volume>7</volume>
<fpage>249</fpage>&#x02013;<lpage>259</lpage>. <pub-id pub-id-type="doi">10.1007/s40121-018-0200-7</pub-id>
<?supplied-pmid 29633177?><pub-id pub-id-type="pmid">29633177</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erb-Downward</surname><given-names>J. R.</given-names></name><name><surname>Thompson</surname><given-names>D. L.</given-names></name><name><surname>Han</surname><given-names>M. K.</given-names></name><name><surname>Freeman</surname><given-names>C. M.</given-names></name><name><surname>McCloskey</surname><given-names>L.</given-names></name><name><surname>Schmidt</surname><given-names>L. A.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Analysis of the lung microbiome in the &#x0201c;healthy&#x0201d; smoker and in COPD.</article-title>
<source><italic>PLoS One</italic></source>
<volume>6</volume>:<issue>e16384</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0016384</pub-id>
<?supplied-pmid 21364979?><pub-id pub-id-type="pmid">21364979</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flemer</surname><given-names>B.</given-names></name><name><surname>Warren</surname><given-names>R. D.</given-names></name><name><surname>Barrett</surname><given-names>M. P.</given-names></name><name><surname>Cisek</surname><given-names>K.</given-names></name><name><surname>Das</surname><given-names>A.</given-names></name><name><surname>Jeffery</surname><given-names>I. B.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>The oral microbiota in colorectal cancer is distinctive and predictive.</article-title>
<source><italic>Gut</italic></source>
<volume>67</volume>
<fpage>1454</fpage>&#x02013;<lpage>1463</lpage>. <pub-id pub-id-type="doi">10.1136/gutjnl-2017-314814</pub-id>
<?supplied-pmid 28988196?><pub-id pub-id-type="pmid">28988196</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gansen</surname><given-names>A.</given-names></name><name><surname>Herrick</surname><given-names>A. M.</given-names></name><name><surname>Dimov</surname><given-names>I. K.</given-names></name><name><surname>Lee</surname><given-names>L. P.</given-names></name><name><surname>Chiu</surname><given-names>D. T.</given-names></name></person-group> (<year>2012</year>). <article-title>Digital LAMP in a sample self-digitization (SD) chip.</article-title>
<source><italic>Lab. Chip.</italic></source>
<volume>12</volume>
<fpage>2247</fpage>&#x02013;<lpage>2254</lpage>. <pub-id pub-id-type="doi">10.1039/c2lc21247a</pub-id>
<?supplied-pmid 22399016?><pub-id pub-id-type="pmid">22399016</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graves</surname><given-names>D. T.</given-names></name><name><surname>Corr&#x000ea;a</surname><given-names>J. D.</given-names></name><name><surname>Silva</surname><given-names>T. A.</given-names></name></person-group> (<year>2019</year>). <article-title>The oral microbiota is modified by systemic diseases.</article-title>
<source><italic>J. Dent. Res.</italic></source>
<volume>98</volume>
<fpage>148</fpage>&#x02013;<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1177/0022034518805739</pub-id>
<?supplied-pmid 30359170?><pub-id pub-id-type="pmid">30359170</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>W.-J.</given-names></name><name><surname>Liang</surname><given-names>W.-H.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Liang</surname><given-names>H.-R.</given-names></name><name><surname>Chen</surname><given-names>Z.-S.</given-names></name><name><surname>Li</surname><given-names>Y.-M.</given-names></name><etal/></person-group> (<year>2020a</year>). <article-title>Comorbidity and its impact on 1,590 patients with COVID-19 in China: a nationwide analysis.</article-title>
<source><italic>medRxiv</italic></source> [<comment>Preprint</comment>] <pub-id pub-id-type="doi">10.1101/2020.02.25.20027664</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>W.-J.</given-names></name><name><surname>Ni</surname><given-names>Z.-Y.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Liang</surname><given-names>W.-H.</given-names></name><name><surname>Ou</surname><given-names>C.-Q.</given-names></name><name><surname>He</surname><given-names>J.-X.</given-names></name><etal/></person-group> (<year>2020b</year>). <article-title>Clinical characteristics of 2019 novel coronavirus infection in China.</article-title>
<source><italic>medRxiv[Preprint]</italic></source>
<pub-id pub-id-type="doi">10.1101/2020.02.06.20020974</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guarner</surname><given-names>J.</given-names></name></person-group> (<year>2020</year>). <article-title>Three Emerging coronaviruses in two decades: the story of SARS, MERS, and now COVID-19.</article-title>
<source><italic>Am. J. Clin. Pathol.</italic></source>
<volume>153</volume>
<fpage>420</fpage>&#x02013;<lpage>421</lpage>. <pub-id pub-id-type="doi">10.1093/ajcp/aqaa029</pub-id>
<?supplied-pmid 32053148?><pub-id pub-id-type="pmid">32053148</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hajishengallis</surname><given-names>G.</given-names></name></person-group> (<year>2015</year>). <article-title>Periodontitis: from microbial immune subversion to systemic inflammation.</article-title>
<source><italic>Nat. Rev. Immunol.</italic></source>
<volume>15</volume>
<fpage>30</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1038/nri3785</pub-id>
<?supplied-pmid 25534621?><pub-id pub-id-type="pmid">25534621</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanada</surname><given-names>S.</given-names></name><name><surname>Pirzadeh</surname><given-names>M.</given-names></name><name><surname>Carver</surname><given-names>K. Y.</given-names></name><name><surname>Deng</surname><given-names>J. C.</given-names></name></person-group> (<year>2018</year>). <article-title>Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia.</article-title>
<source><italic>Front. Immunol.</italic></source>
<volume>9</volume>:<issue>2640</issue>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.02640</pub-id>
<?supplied-pmid 30505304?><pub-id pub-id-type="pmid">30505304</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashemzadeh</surname><given-names>M. S.</given-names></name><name><surname>Rasouli</surname><given-names>R.</given-names></name><name><surname>Zahraei</surname><given-names>B.</given-names></name><name><surname>Izadi</surname><given-names>M.</given-names></name><name><surname>Tat</surname><given-names>M.</given-names></name><name><surname>Saadat</surname><given-names>S. H.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Development of dual TaqMan based one-step rRT-PCR assay panel for rapid and accurate diagnostic test of MERS-CoV: a novel human coronavirus, ahead of hajj pilgrimage.</article-title>
<source><italic>Iran. Red. Crescent. Med. J.</italic></source>
<volume>18</volume>:<issue>e23874</issue>. <pub-id pub-id-type="doi">10.5812/ircmj.23874</pub-id>
<?supplied-pmid 28191331?><pub-id pub-id-type="pmid">28191331</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>M.</given-names></name><name><surname>Kleine-Weber</surname><given-names>H.</given-names></name><name><surname>Schroeder</surname><given-names>S.</given-names></name><name><surname>Kr&#x000fc;ger</surname><given-names>N.</given-names></name><name><surname>Herrler</surname><given-names>T.</given-names></name><name><surname>Erichsen</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.</article-title>
<source><italic>Cell</italic></source>
<volume>181</volume>
<fpage>271</fpage>&#x02013;<lpage>280.e278</lpage>.<pub-id pub-id-type="pmid">32142651</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>C.</given-names></name><name><surname>Aung</surname><given-names>M. M.</given-names></name><name><surname>Kanagasabai</surname><given-names>K.</given-names></name><name><surname>Lim</surname><given-names>C. A.</given-names></name><name><surname>Liang</surname><given-names>S.</given-names></name><name><surname>Tan</surname><given-names>K. S.</given-names></name></person-group> (<year>2018</year>). <article-title>The association between oral health status and respiratory pathogen colonization with pneumonia risk in institutionalized adults.</article-title>
<source><italic>Int. J. Dent. Hygiene</italic></source>
<volume>16</volume>
<fpage>e96</fpage>&#x02013;<lpage>e102</lpage>. <pub-id pub-id-type="doi">10.1111/idh.12321</pub-id>
<?supplied-pmid 29120096?><pub-id pub-id-type="pmid">29120096</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hua</surname><given-names>F.</given-names></name><name><surname>Xie</surname><given-names>H.</given-names></name><name><surname>Worthington</surname><given-names>H. V.</given-names></name><name><surname>Furness</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia.</article-title>
<source><italic>Cochrane Database Syst. Rev.</italic></source>
<volume>10</volume>:<issue>CD008367</issue>.</mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Ren</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.</article-title>
<source><italic>Lancet</italic></source>
<volume>395</volume>
<fpage>497</fpage>&#x02013;<lpage>506</lpage>.<pub-id pub-id-type="pmid">31986264</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huffnagle</surname><given-names>G. B.</given-names></name><name><surname>Dickson</surname><given-names>R. P.</given-names></name><name><surname>Lukacs</surname><given-names>N. W.</given-names></name></person-group> (<year>2017</year>). <article-title>The respiratory tract microbiome and lung inflammation: a two-way street.</article-title>
<source><italic>Mucosal Immunol.</italic></source>
<volume>10</volume>
<fpage>299</fpage>&#x02013;<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2016.108</pub-id>
<?supplied-pmid 27966551?><pub-id pub-id-type="pmid">27966551</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>D. S.</given-names></name><name><surname>Zumla</surname><given-names>A.</given-names></name></person-group> (<year>2019</year>). <article-title>Severe acute respiratory syndrome: historical, epidemiologic, and clinical features.</article-title>
<source><italic>Infect. Dis. Clin.</italic></source>
<volume>33</volume>
<fpage>869</fpage>&#x02013;<lpage>889</lpage>.</mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iki</surname><given-names>H.</given-names></name><name><surname>Sawa</surname><given-names>S.</given-names></name><name><surname>Teranishi</surname><given-names>T.</given-names></name><name><surname>Tomita</surname><given-names>M.</given-names></name><name><surname>Nishii</surname><given-names>K.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name></person-group> (<year>2016</year>). <article-title>Effect of exercise therapy on cytokine secretion in the saliva of bedridden patients.</article-title>
<source><italic>J. Phys. Ther. Sci.</italic></source>
<volume>28</volume>
<fpage>2871</fpage>&#x02013;<lpage>2876</lpage>. <pub-id pub-id-type="doi">10.1589/jpts.28.2871</pub-id>
<?supplied-pmid 27821953?><pub-id pub-id-type="pmid">27821953</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwata-Yoshikawa</surname><given-names>N.</given-names></name><name><surname>Okamura</surname><given-names>T.</given-names></name><name><surname>Shimizu</surname><given-names>Y.</given-names></name><name><surname>Hasegawa</surname><given-names>H.</given-names></name><name><surname>Takeda</surname><given-names>M.</given-names></name><name><surname>Nagata</surname><given-names>N.</given-names></name></person-group> (<year>2019</year>). <article-title>TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection.</article-title>
<source><italic>J. Virol.</italic></source>
<volume>93</volume>:<issue>e01815-18</issue>. <pub-id pub-id-type="doi">10.1128/JVI.01815-18</pub-id>
<?supplied-pmid 30626688?><pub-id pub-id-type="pmid">30626688</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>R. D.</given-names></name><name><surname>Liu</surname><given-names>M. Q.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Shan</surname><given-names>C.</given-names></name><name><surname>Zhou</surname><given-names>Y. W.</given-names></name><name><surname>Shen</surname><given-names>X. R.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2.</article-title>
<source><italic>Cell</italic></source>
<volume>182</volume>
<fpage>50</fpage>&#x02013;<lpage>58.e8</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2020.05.027</pub-id>
<?supplied-pmid 32516571?><pub-id pub-id-type="pmid">32516571</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kageyama</surname><given-names>S.</given-names></name><name><surname>Takeshita</surname><given-names>T.</given-names></name><name><surname>Furuta</surname><given-names>M.</given-names></name><name><surname>Tomioka</surname><given-names>M.</given-names></name><name><surname>Asakawa</surname><given-names>M.</given-names></name><name><surname>Suma</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Relationships of variations in the tongue microbiota and pneumonia mortality in nursing home residents.</article-title>
<source><italic>J. Gerontol. Ser. A</italic></source>
<volume>73</volume>
<fpage>1097</fpage>&#x02013;<lpage>1102</lpage>. <pub-id pub-id-type="doi">10.1093/gerona/glx205</pub-id>
<?supplied-pmid 29053769?><pub-id pub-id-type="pmid">29053769</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamio</surname><given-names>N.</given-names></name><name><surname>Imai</surname><given-names>K.</given-names></name><name><surname>Shimizu</surname><given-names>K.</given-names></name><name><surname>Cueno</surname><given-names>M. E.</given-names></name><name><surname>Tamura</surname><given-names>M.</given-names></name><name><surname>Saito</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Neuraminidase-producing oral mitis group streptococci potentially contribute to influenza viral infection and reduction in antiviral efficacy of zanamivir.</article-title>
<source><italic>Cell. Mol. Life Sci.</italic></source>
<volume>72</volume>
<fpage>357</fpage>&#x02013;<lpage>366</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-014-1669-1</pub-id>
<?supplied-pmid 25001578?><pub-id pub-id-type="pmid">25001578</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kampf</surname><given-names>G.</given-names></name><name><surname>Todt</surname><given-names>D.</given-names></name><name><surname>Pfaender</surname><given-names>S.</given-names></name><name><surname>Steinmann</surname><given-names>E.</given-names></name></person-group> (<year>2020</year>). <article-title>Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.</article-title>
<source><italic>J. Hosp. Infect.</italic></source>
<volume>104</volume>
<fpage>246</fpage>&#x02013;<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1016/j.jhin.2020.01.022</pub-id>
<?supplied-pmid 32035997?><pub-id pub-id-type="pmid">32035997</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kariwa</surname><given-names>H.</given-names></name><name><surname>Fujii</surname><given-names>N.</given-names></name><name><surname>Takashima</surname><given-names>I.</given-names></name></person-group> (<year>2006</year>). <article-title>Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents.</article-title>
<source><italic>Dermatology</italic></source>
<volume>212(Suppl 1)</volume>
<fpage>119</fpage>&#x02013;<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1159/000089211</pub-id>
<?supplied-pmid 16490989?><pub-id pub-id-type="pmid">16490989</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ke</surname><given-names>X.</given-names></name><name><surname>Lei</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Yan</surname><given-names>F.</given-names></name></person-group> (<year>2016</year>). <article-title>Manipulation of necroptosis by <italic>Porphyromonas gingivalis</italic> in periodontitis development.</article-title>
<source><italic>Mol. Immunol.</italic></source>
<volume>77</volume>
<fpage>8</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.molimm.2016.07.010</pub-id>
<?supplied-pmid 27449906?><pub-id pub-id-type="pmid">27449906</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>A. A.</given-names></name><name><surname>Khan</surname><given-names>Z.</given-names></name></person-group> (<year>2020</year>). <article-title>COVID-2019 associated overexpressed <italic>Prevotella proteins</italic> mediated host-pathogen interactions and their role in coronavirus outbreak.</article-title>
<source><italic>Bioinformatics</italic></source>
<volume>36</volume>
<fpage>4065</fpage>&#x02013;<lpage>4069</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btaa285</pub-id>
<?supplied-pmid 32374823?><pub-id pub-id-type="pmid">32374823</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>M. N.</given-names></name><name><surname>Ko</surname><given-names>Y. J.</given-names></name><name><surname>Seong</surname><given-names>M. W.</given-names></name><name><surname>Kim</surname><given-names>J. S.</given-names></name><name><surname>Shin</surname><given-names>B. M.</given-names></name><name><surname>Sung</surname><given-names>H.</given-names></name></person-group> (<year>2016</year>). <article-title>Analytical and clinical validation of six commercial middle east respiratory syndrome coronavirus RNA detection kits based on real-time reverse-transcription PCR.</article-title>
<source><italic>Ann. Lab. Med.</italic></source>
<volume>36</volume>
<fpage>450</fpage>&#x02013;<lpage>456</lpage>. <pub-id pub-id-type="doi">10.3343/alm.2016.36.5.450</pub-id>
<?supplied-pmid 27374710?><pub-id pub-id-type="pmid">27374710</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>E. Y.</given-names></name><name><surname>Monteforte</surname><given-names>B.</given-names></name><name><surname>Gupta</surname><given-names>A.</given-names></name><name><surname>Jiang</surname><given-names>W.</given-names></name><name><surname>May</surname><given-names>L.</given-names></name><name><surname>Hsieh</surname><given-names>Y.-H.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis.</article-title>
<source><italic>Influenza Respir. Viruses</italic></source>
<volume>10</volume>
<fpage>394</fpage>&#x02013;<lpage>403</lpage>. <pub-id pub-id-type="doi">10.1111/irv.12398</pub-id>
<?supplied-pmid 27232677?><pub-id pub-id-type="pmid">27232677</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname><given-names>J.</given-names></name><name><surname>Nigam</surname><given-names>Y.</given-names></name><name><surname>Jones</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>Effects of bedrest 1: cardiovascular, respiratory and haematological systems.</article-title>
<source><italic>Nurs. Times</italic></source>
<volume>105</volume>
<fpage>16</fpage>&#x02013;<lpage>20</lpage>.</mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname><given-names>H.-W.</given-names></name><name><surname>Kim</surname><given-names>M. S.</given-names></name><name><surname>Lee</surname><given-names>J.-S.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Park</surname><given-names>S.-J.</given-names></name></person-group> (<year>2015</year>). <article-title>Changes in the swine gut microbiota in response to porcine epidemic diarrhea infection.</article-title>
<source><italic>Microbes Environ.</italic></source>
<volume>30</volume>
<fpage>284</fpage>&#x02013;<lpage>287</lpage>. <pub-id pub-id-type="doi">10.1264/jsme2.ME15046</pub-id>
<?supplied-pmid 26212519?><pub-id pub-id-type="pmid">26212519</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krone</surname><given-names>C. L.</given-names></name><name><surname>van de Groep</surname><given-names>K.</given-names></name><name><surname>Trzcinski</surname><given-names>K.</given-names></name><name><surname>Sanders</surname><given-names>E. A.</given-names></name><name><surname>Bogaert</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>Immunosenescence and pneumococcal disease: an imbalance in host-pathogen interactions.</article-title>
<source><italic>Lancet Respir. Med.</italic></source>
<volume>2</volume>
<fpage>141</fpage>&#x02013;<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1016/s2213-2600(13)70165-6</pub-id><pub-id pub-id-type="pmid">24503269</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>P. S.</given-names></name></person-group> (<year>2017</year>). <article-title>From focal sepsis to periodontal medicine: a century of exploring the role of the oral microbiome in systemic disease.</article-title>
<source><italic>J. Physiol.</italic></source>
<volume>595</volume>
<fpage>465</fpage>&#x02013;<lpage>476</lpage>. <pub-id pub-id-type="doi">10.1113/jp272427</pub-id>
<?supplied-pmid 27426277?><pub-id pub-id-type="pmid">27426277</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuroda</surname><given-names>M.</given-names></name><name><surname>Katano</surname><given-names>H.</given-names></name><name><surname>Nakajima</surname><given-names>N.</given-names></name><name><surname>Tobiume</surname><given-names>M.</given-names></name><name><surname>Ainai</surname><given-names>A.</given-names></name><name><surname>Sekizuka</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Characterization of quasispecies of pandemic 2009 influenza A virus (A/H1N1/2009) by de novo sequencing using a next-generation DNA sequencer.</article-title>
<source><italic>PLoS One</italic></source>
<volume>5</volume>:<issue>e10256</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0010256</pub-id>
<?supplied-pmid 20428231?><pub-id pub-id-type="pmid">20428231</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamers</surname><given-names>M. M.</given-names></name><name><surname>Beumer</surname><given-names>J.</given-names></name><name><surname>van der Vaart</surname><given-names>J.</given-names></name><name><surname>Knoops</surname><given-names>K.</given-names></name><name><surname>Puschhof</surname><given-names>J.</given-names></name><name><surname>Breugem</surname><given-names>T. I.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>SARS-CoV-2 productively infects human gut enterocytes.</article-title>
<source><italic>Science</italic></source>
<volume>369</volume>
<fpage>50</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1126/science.abc1669</pub-id>
<?supplied-pmid 32358202?><pub-id pub-id-type="pmid">32358202</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lansbury</surname><given-names>L.</given-names></name><name><surname>Lim</surname><given-names>B.</given-names></name><name><surname>Baskaran</surname><given-names>V.</given-names></name><name><surname>Lim</surname><given-names>W. S.</given-names></name></person-group> (<year>2020</year>). <article-title>Co-infections in people with COVID-19: a systematic review and meta-analysis.</article-title>
<source><italic>J. Infect.</italic></source>
<pub-id pub-id-type="doi">10.1016/j.jinf.2020.05.046</pub-id>
<comment>[Epub ahead of print]</comment>. <?supplied-pmid 32473235?><pub-id pub-id-type="pmid">32473235</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsen</surname><given-names>J. M.</given-names></name></person-group> (<year>2017</year>). <article-title>The immune response to <italic>Prevotella</italic> bacteria in chronic inflammatory disease.</article-title>
<source><italic>Immunology</italic></source>
<volume>151</volume>
<fpage>363</fpage>&#x02013;<lpage>374</lpage>. <pub-id pub-id-type="doi">10.1111/imm.12760</pub-id>
<?supplied-pmid 28542929?><pub-id pub-id-type="pmid">28542929</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Letko</surname><given-names>M.</given-names></name><name><surname>Marzi</surname><given-names>A.</given-names></name><name><surname>Munster</surname><given-names>V.</given-names></name></person-group> (<year>2020</year>). <article-title>Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.</article-title>
<source><italic>Nat. Microbiol.</italic></source>
<volume>5</volume>
<fpage>562</fpage>&#x02013;<lpage>569</lpage>. <pub-id pub-id-type="doi">10.1038/s41564-020-0688-y</pub-id>
<?supplied-pmid 32094589?><pub-id pub-id-type="pmid">32094589</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>R. K.</given-names></name><name><surname>Zhou</surname><given-names>J. W.</given-names></name><name><surname>Guan</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>S. K.</given-names></name><name><surname>Yang</surname><given-names>Z. F.</given-names></name><name><surname>Tsui</surname><given-names>S. K.</given-names></name></person-group> (<year>2013</year>). <article-title>Modulation of potential respiratory pathogens by pH1N1 viral infection.</article-title>
<source><italic>Clin. Microbiol. Infect.</italic></source>
<volume>19</volume>
<fpage>930</fpage>&#x02013;<lpage>935</lpage>. <pub-id pub-id-type="doi">10.1111/1469-0691.12054</pub-id>
<?supplied-pmid 23167452?><pub-id pub-id-type="pmid">23167452</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Fan</surname><given-names>Y.</given-names></name><name><surname>Lai</surname><given-names>Y.</given-names></name><name><surname>Han</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Zhou</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Coronavirus infections and immune responses.</article-title>
<source><italic>J. Med. Virol.</italic></source>
<volume>92</volume>
<fpage>424</fpage>&#x02013;<lpage>432</lpage>.<pub-id pub-id-type="pmid">31981224</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name></person-group> (<year>2005</year>). <article-title>Organism distribution and drug resistance analysis in 13 cases of SARS patients with secondary infection.</article-title>
<source><italic>Chin. J. Infec. Contl.</italic></source>
<volume>4</volume>
<fpage>252</fpage>&#x02013;<lpage>254</lpage>.</mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>He</surname><given-names>Z.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Yuan</surname><given-names>M.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Phylogenetic and functional gene structure shifts of the oral microbiomes in periodontitis patients.</article-title>
<source><italic>ISME J.</italic></source>
<volume>8</volume>
<fpage>1879</fpage>&#x02013;<lpage>1891</lpage>. <pub-id pub-id-type="doi">10.1038/ismej.2014.28</pub-id>
<?supplied-pmid 24671083?><pub-id pub-id-type="pmid">24671083</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>K.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Tu</surname><given-names>Q.</given-names></name><name><surname>Yao</surname><given-names>Y.</given-names></name><name><surname>Cui</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Salivary mycobiome dysbiosis and its potential impact on bacteriome shifts and host immunity in oral lichen planus.</article-title>
<source><italic>Int. J. Oral Sci.</italic></source>
<volume>11</volume>
<fpage>1</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">30602784</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>Q.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Shen</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name></person-group> (<year>2020</year>). <article-title>Organoids as a powerful model for respiratory diseases.</article-title>
<source><italic>Stem Cells Int.</italic></source>
<volume>2020</volume>
<issue>5847876</issue>. <pub-id pub-id-type="doi">10.1155/2020/5847876</pub-id>
<?supplied-pmid 32256609?><pub-id pub-id-type="pmid">32256609</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Meng</surname><given-names>L.</given-names></name></person-group> (<year>2020</year>). <article-title>The prevention and control of a new coronavirus infection in department of stomatology.</article-title>
<source><italic>Zhonghua kou qiang yi xue za zhi</italic></source>
<volume>55</volume>:<issue>E001</issue>.</mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H. X.</given-names></name><name><surname>Tao</surname><given-names>L. L.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Zhu</surname><given-names>Y. G.</given-names></name><name><surname>Zheng</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects.</article-title>
<source><italic>Int. J. Cancer</italic></source>
<volume>142</volume>
<fpage>769</fpage>&#x02013;<lpage>778</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.31098</pub-id>
<?supplied-pmid 29023689?><pub-id pub-id-type="pmid">29023689</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>H. F.</given-names></name><name><surname>Li</surname><given-names>A.</given-names></name><name><surname>Zhang</surname><given-names>T.</given-names></name><name><surname>Ren</surname><given-names>Z. G.</given-names></name><name><surname>He</surname><given-names>K. X.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Disordered oropharyngeal microbial communities in H7N9 patients with or without secondary bacterial lung infection.</article-title>
<source><italic>Emerg. Microbes Infect.</italic></source>
<volume>6</volume>:<issue>e112</issue>. <pub-id pub-id-type="doi">10.1038/emi.2017.101</pub-id>
<?supplied-pmid 29259328?><pub-id pub-id-type="pmid">29259328</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacIntyre</surname><given-names>C. R.</given-names></name><name><surname>Chughtai</surname><given-names>A. A.</given-names></name><name><surname>Barnes</surname><given-names>M.</given-names></name><name><surname>Ridda</surname><given-names>I.</given-names></name><name><surname>Seale</surname><given-names>H.</given-names></name><name><surname>Toms</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09.</article-title>
<source><italic>BMC Infect. Dis.</italic></source>
<volume>18</volume>:<issue>637</issue>. <pub-id pub-id-type="doi">10.1186/s12879-018-3548-0</pub-id>
<?supplied-pmid 30526505?><pub-id pub-id-type="pmid">30526505</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mammen</surname><given-names>M. J.</given-names></name><name><surname>Scannapieco</surname><given-names>F. A.</given-names></name><name><surname>Sethi</surname><given-names>S.</given-names></name></person-group> (<year>2020</year>). <article-title>Oral-lung microbiome interactions in lung diseases.</article-title>
<source><italic>Periodontology 2000</italic></source>
<volume>83</volume>
<fpage>234</fpage>&#x02013;<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1111/prd.12301</pub-id>
<?supplied-pmid 32385873?><pub-id pub-id-type="pmid">32385873</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Man</surname><given-names>W. H.</given-names></name><name><surname>Clerc</surname><given-names>M.</given-names></name><name><surname>de Steenhuijsen Piters</surname><given-names>W. A. A.</given-names></name><name><surname>van Houten</surname><given-names>M. A.</given-names></name><name><surname>Chu</surname><given-names>M.</given-names></name><name><surname>Kool</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Loss of microbial topography between oral and nasopharyngeal microbiota and development of respiratory infections early in life.</article-title>
<source><italic>Am. J. Respir. Crit. Care Med.</italic></source>
<volume>200</volume>
<fpage>760</fpage>&#x02013;<lpage>770</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.201810-1993OC</pub-id>
<?supplied-pmid 30883192?><pub-id pub-id-type="pmid">30883192</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McArdle</surname><given-names>A. J.</given-names></name><name><surname>Turkova</surname><given-names>A.</given-names></name><name><surname>Cunnington</surname><given-names>A. J.</given-names></name></person-group> (<year>2018</year>). <article-title>When do co-infections matter?</article-title>
<source><italic>Curr. Opin. Infect. Dis.</italic></source>
<volume>31</volume>
<fpage>209</fpage>&#x02013;<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1097/QCO.0000000000000447</pub-id>
<?supplied-pmid 29698255?><pub-id pub-id-type="pmid">29698255</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCullers</surname><given-names>J. A.</given-names></name></person-group> (<year>2014</year>). <article-title>The co-pathogenesis of influenza viruses with bacteria in the lung.</article-title>
<source><italic>Nat. Rev. Microbiol.</italic></source>
<volume>12</volume>
<fpage>252</fpage>&#x02013;<lpage>262</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro3231</pub-id>
<?supplied-pmid 24590244?><pub-id pub-id-type="pmid">24590244</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>D. P.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Weinberg</surname><given-names>A.</given-names></name><name><surname>Lamont</surname><given-names>R. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Transcriptome analysis of <italic>Porphyromonas gingivalis</italic> and <italic>Acinetobacter baumannii</italic> in polymicrobial communities.</article-title>
<source><italic>Mol. Oral Microbiol.</italic></source>
<volume>33</volume>
<fpage>364</fpage>&#x02013;<lpage>377</lpage>. <pub-id pub-id-type="doi">10.1111/omi.12238</pub-id>
<?supplied-pmid 29939498?><pub-id pub-id-type="pmid">29939498</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>S. C.</given-names></name><name><surname>Penrice-Randal</surname><given-names>R.</given-names></name><name><surname>Alruwaili</surname><given-names>M.</given-names></name><name><surname>Dong</surname><given-names>X.</given-names></name><name><surname>Pullan</surname><given-names>S. T.</given-names></name><name><surname>Carter</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Amplicon based MinION sequencing of SARS-CoV-2 and metagenomic characterisation of nasopharyngeal swabs from patients with COVID-19.</article-title>
<source><italic>medRxiv</italic></source> [<comment>Preprint</comment>] <pub-id pub-id-type="doi">10.1101/2020.03.05.20032011</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morens</surname><given-names>D. M.</given-names></name><name><surname>Taubenberger</surname><given-names>J. K.</given-names></name><name><surname>Fauci</surname><given-names>A. S.</given-names></name></person-group> (<year>2008</year>). <article-title>Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness.</article-title>
<source><italic>J. Infect. Dis.</italic></source>
<volume>198</volume>
<fpage>962</fpage>&#x02013;<lpage>970</lpage>. <pub-id pub-id-type="doi">10.1086/591708</pub-id>
<?supplied-pmid 18710327?><pub-id pub-id-type="pmid">18710327</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muscedere</surname><given-names>J.</given-names></name><name><surname>Ofner</surname><given-names>M.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Long</surname><given-names>J.</given-names></name><name><surname>Lamontagne</surname><given-names>F.</given-names></name><name><surname>Cook</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>The occurrence and impact of bacterial organisms complicating critical care illness associated with 2009 influenza A(H1N1) infection.</article-title>
<source><italic>Chest</italic></source>
<volume>144</volume>
<fpage>39</fpage>&#x02013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1378/chest.12-1861</pub-id>
<?supplied-pmid 23392627?><pub-id pub-id-type="pmid">23392627</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><collab>National Health Commission of the People&#x02019;s Republic of China</collab> (<year>2020</year>). <source><italic>Guideline for the Diagnosis and Treatment of Novel Coronavirus Pneumonia</italic></source>, <edition>7th Edn</edition> Available online at: <ext-link ext-link-type="uri" xlink:href="http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml">http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml</ext-link>
<comment>(accessed March 3, 2020)</comment></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noh</surname><given-names>J. Y.</given-names></name><name><surname>Yoon</surname><given-names>S.-W.</given-names></name><name><surname>Kim</surname><given-names>D.-J.</given-names></name><name><surname>Lee</surname><given-names>M.-S.</given-names></name><name><surname>Kim</surname><given-names>J.-H.</given-names></name><name><surname>Na</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Simultaneous detection of severe acute respiratory syndrome, Middle East respiratory syndrome, and related bat coronaviruses by real-time reverse transcription PCR.</article-title>
<source><italic>Arch. Virol.</italic></source>
<volume>162</volume>
<fpage>1617</fpage>&#x02013;<lpage>1623</lpage>. <pub-id pub-id-type="doi">10.1007/s00705-017-3281-9</pub-id>
<?supplied-pmid 28220326?><pub-id pub-id-type="pmid">28220326</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsen</surname><given-names>I.</given-names></name></person-group> (<year>2015</year>). <article-title>From the acta prize lecture 2014: the periodontal-systemic connection seen from a microbiological standpoint.</article-title>
<source><italic>Acta Odontol. Scand.</italic></source>
<volume>73</volume>
<fpage>563</fpage>&#x02013;<lpage>568</lpage>. <pub-id pub-id-type="doi">10.3109/00016357.2015.1007480</pub-id>
<?supplied-pmid 25891035?><pub-id pub-id-type="pmid">25891035</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pace</surname><given-names>C. C.</given-names></name><name><surname>McCullough</surname><given-names>G. H.</given-names></name></person-group> (<year>2010</year>). <article-title>The association between oral microorgansims and aspiration pneumonia in the institutionalized elderly: review and recommendations.</article-title>
<source><italic>Dysphagia</italic></source>
<volume>25</volume>
<fpage>307</fpage>&#x02013;<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1007/s00455-010-9298-9</pub-id>
<?supplied-pmid 20824288?><pub-id pub-id-type="pmid">20824288</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paju</surname><given-names>S.</given-names></name><name><surname>Scannapieco</surname><given-names>F. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Oral biofilms, periodontitis, and pulmonary infections.</article-title>
<source><italic>Oral. Dis.</italic></source>
<volume>13</volume>
<fpage>508</fpage>&#x02013;<lpage>512</lpage>. <pub-id pub-id-type="doi">10.1111/j.1601-0825.2007.01410a.x</pub-id>
<?supplied-pmid 17944664?><pub-id pub-id-type="pmid">17944664</pub-id></mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>D.</given-names></name><name><surname>Yang</surname><given-names>P.</given-names></name><name><surname>Poon</surname><given-names>L. L.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name></person-group> (<year>2020</year>). <article-title>Viral load of SARS-CoV-2 in clinical samples.</article-title>
<source><italic>Lancet Infect. Dis.</italic></source>
<volume>20</volume>
<fpage>411</fpage>&#x02013;<lpage>412</lpage>. <pub-id pub-id-type="doi">10.1016/s1473-3099(20)30113-4</pub-id><pub-id pub-id-type="pmid">32105638</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paolicelli</surname><given-names>G.</given-names></name><name><surname>Luca</surname><given-names>A. D.</given-names></name><name><surname>Jose</surname><given-names>S. S.</given-names></name><name><surname>Antonini</surname><given-names>M.</given-names></name><name><surname>Teloni</surname><given-names>I.</given-names></name><name><surname>Fric</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Using lung organoids to investigate epithelial barrier complexity and IL-17 signaling during respiratory infection.</article-title>
<source><italic>Front. Immunol.</italic></source>
<volume>10</volume>:<issue>323</issue>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.00323</pub-id>
<?supplied-pmid 30873173?><pub-id pub-id-type="pmid">30873173</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peddu</surname><given-names>V.</given-names></name><name><surname>Shean</surname><given-names>R. C.</given-names></name><name><surname>Xie</surname><given-names>H.</given-names></name><name><surname>Shrestha</surname><given-names>L.</given-names></name><name><surname>Perchetti</surname><given-names>G. A.</given-names></name><name><surname>Minot</surname><given-names>S. S.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Metagenomic analysis reveals clinical SARS-CoV-2 infection and bacterial or viral superinfection and colonization.</article-title>
<source><italic>Clin. Chem.</italic></source>
<volume>66</volume>
<fpage>966</fpage>&#x02013;<lpage>972</lpage>. <pub-id pub-id-type="doi">10.1093/clinchem/hvaa106</pub-id>
<?supplied-pmid 32379863?><pub-id pub-id-type="pmid">32379863</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Popkin</surname><given-names>D. L.</given-names></name><name><surname>Zilka</surname><given-names>S.</given-names></name><name><surname>Dimaano</surname><given-names>M.</given-names></name><name><surname>Fujioka</surname><given-names>H.</given-names></name><name><surname>Rackley</surname><given-names>C.</given-names></name><name><surname>Salata</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Cetylpyridinium chloride (CPC) exhibits potent, rapid activity against influenza viruses in vitro and in vivo.</article-title>
<source><italic>Pathog. Immun.</italic></source>
<volume>2</volume>
<fpage>252</fpage>&#x02013;<lpage>269</lpage>. <pub-id pub-id-type="doi">10.20411/pai.v2i2.200</pub-id>
<?supplied-pmid 28936484?><pub-id pub-id-type="pmid">28936484</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pragman</surname><given-names>A. A.</given-names></name><name><surname>Lyu</surname><given-names>T.</given-names></name><name><surname>Baller</surname><given-names>J. A.</given-names></name><name><surname>Gould</surname><given-names>T. J.</given-names></name><name><surname>Kelly</surname><given-names>R. F.</given-names></name><name><surname>Reilly</surname><given-names>C. S.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease.</article-title>
<source><italic>Microbiome</italic></source>
<volume>6</volume>:<issue>7</issue>. <pub-id pub-id-type="doi">10.1186/s40168-017-0381-4</pub-id>
<?supplied-pmid 29316977?><pub-id pub-id-type="pmid">29316977</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quantius</surname><given-names>J.</given-names></name><name><surname>Schmoldt</surname><given-names>C.</given-names></name><name><surname>Vazquez-Armendariz</surname><given-names>A. I.</given-names></name><name><surname>Becker</surname><given-names>C.</given-names></name><name><surname>El Agha</surname><given-names>E.</given-names></name><name><surname>Wilhelm</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Influenza virus infects epithelial stem/progenitor cells of the distal lung: impact on fgfr2b-driven epithelial repair.</article-title>
<source><italic>PLoS Pathog.</italic></source>
<volume>12</volume>:<issue>e1005544</issue>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1005544</pub-id>
<?supplied-pmid 27322618?><pub-id pub-id-type="pmid">27322618</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rawson</surname><given-names>T. M.</given-names></name><name><surname>Moore</surname><given-names>L. S. P.</given-names></name><name><surname>Zhu</surname><given-names>N.</given-names></name><name><surname>Ranganathan</surname><given-names>N.</given-names></name><name><surname>Skolimowska</surname><given-names>K.</given-names></name><name><surname>Gilchrist</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Bacterial and fungal co-infection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing.</article-title>
<source><italic>Clin. Infect. Dis.</italic></source>
<pub-id pub-id-type="doi">10.1093/cid/ciaa530</pub-id>
<comment>[Epub ahead of print]</comment>. <?supplied-pmid 32358954?><pub-id pub-id-type="pmid">32358954</pub-id></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rems</surname><given-names>L.</given-names></name><name><surname>Kawale</surname><given-names>D.</given-names></name><name><surname>Lee</surname><given-names>L. J.</given-names></name><name><surname>Boukany</surname><given-names>P. E.</given-names></name></person-group> (<year>2016</year>). <article-title>Flow of DNA in micro/nanofluidics: from fundamentals to applications.</article-title>
<source><italic>Biomicrofluidics</italic></source>
<volume>10</volume>:<issue>043403</issue>
<pub-id pub-id-type="doi">10.1063/1.4958719</pub-id></mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>L. L.</given-names></name><name><surname>Wang</surname><given-names>Y. M.</given-names></name><name><surname>Wu</surname><given-names>Z. Q.</given-names></name><name><surname>Xiang</surname><given-names>Z. C.</given-names></name><name><surname>Guo</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study.</article-title>
<source><italic>Chin. Med. J. (Engl.)</italic></source>
<volume>133</volume>
<fpage>1015</fpage>&#x02013;<lpage>1024</lpage>. <pub-id pub-id-type="doi">10.1097/cm9.0000000000000722</pub-id>
<?supplied-pmid 32004165?><pub-id pub-id-type="pmid">32004165</pub-id></mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizzo</surname><given-names>C.</given-names></name><name><surname>Caporali</surname><given-names>M. G.</given-names></name><name><surname>Rota</surname><given-names>M. C.</given-names></name></person-group> (<year>2010</year>). <article-title>Pandemic influenza and pneumonia due to <italic>Legionella pneumophila</italic>: a frequently underestimated coinfection.</article-title>
<source><italic>Clin. Infect. Dis.</italic></source>
<volume>51</volume>:<issue>115</issue>. <pub-id pub-id-type="doi">10.1086/653444</pub-id>
<?supplied-pmid 20518675?><pub-id pub-id-type="pmid">20518675</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saeb</surname><given-names>A. T. M.</given-names></name><name><surname>Al-Rubeaan</surname><given-names>K. A.</given-names></name><name><surname>Aldosary</surname><given-names>K.</given-names></name><name><surname>Udaya Raja</surname><given-names>G. K.</given-names></name><name><surname>Mani</surname><given-names>B.</given-names></name><name><surname>Abouelhoda</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Relative reduction of biological and phylogenetic diversity of the oral microbiota of diabetes and pre-diabetes patients.</article-title>
<source><italic>Microb. Pathog.</italic></source>
<volume>128</volume>
<fpage>215</fpage>&#x02013;<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1016/j.micpath.2019.01.009</pub-id>
<?supplied-pmid 30625362?><pub-id pub-id-type="pmid">30625362</pub-id></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segal</surname><given-names>L. N.</given-names></name><name><surname>Alekseyenko</surname><given-names>A. V.</given-names></name><name><surname>Clemente</surname><given-names>J. C.</given-names></name><name><surname>Kulkarni</surname><given-names>R.</given-names></name><name><surname>Wu</surname><given-names>B.</given-names></name><name><surname>Gao</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation.</article-title>
<source><italic>Microbiome</italic></source>
<volume>1</volume>:<issue>19</issue>. <pub-id pub-id-type="doi">10.1186/2049-2618-1-19</pub-id>
<?supplied-pmid 24450871?><pub-id pub-id-type="pmid">24450871</pub-id></mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segal</surname><given-names>L. N.</given-names></name><name><surname>Clemente</surname><given-names>J. C.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Ruan</surname><given-names>C.</given-names></name><name><surname>Cao</surname><given-names>J.</given-names></name><name><surname>Danckers</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Anaerobic bacterial fermentation products increase tuberculosis risk in antiretroviral-drug-treated HIV patients.</article-title>
<source><italic>Cell Host Microbe</italic></source>
<volume>21</volume>
<fpage>530</fpage>&#x02013;<lpage>537.e4</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2017.03.003</pub-id>
<?supplied-pmid 28366509?><pub-id pub-id-type="pmid">28366509</pub-id></mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segal</surname><given-names>L. N.</given-names></name><name><surname>Clemente</surname><given-names>J. C.</given-names></name><name><surname>Tsay</surname><given-names>J. C.</given-names></name><name><surname>Koralov</surname><given-names>S. B.</given-names></name><name><surname>Keller</surname><given-names>B. C.</given-names></name><name><surname>Wu</surname><given-names>B. G.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype.</article-title>
<source><italic>Nat. Microbiol.</italic></source>
<volume>1</volume>:<issue>16031</issue>. <pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.31</pub-id>
<?supplied-pmid 27572644?><pub-id pub-id-type="pmid">27572644</pub-id></mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>R.</given-names></name><name><surname>Agarwal</surname><given-names>M.</given-names></name><name><surname>Gupta</surname><given-names>M.</given-names></name><name><surname>Somendra</surname><given-names>S.</given-names></name><name><surname>Saxena</surname><given-names>S. K.</given-names></name></person-group> (<year>2020</year>). <article-title>Clinical characteristics and differential clinical diagnosis of novel coronavirus disease 2019 (COVID-19).</article-title>
<source><italic>Coronavirus Dis. 2019 (COVID-19)</italic></source>
<volume>2020</volume>
<fpage>55</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1007/978-981-15-4814-7_6</pub-id></mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>L.</given-names></name><name><surname>Niu</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Huang</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Zhu</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses.</article-title>
<source><italic>J. Virol.</italic></source>
<volume>93</volume>:<issue>e00023-19</issue>. <pub-id pub-id-type="doi">10.1128/JVI.00023-19</pub-id>
<?supplied-pmid 30918074?><pub-id pub-id-type="pmid">30918074</pub-id></mixed-citation></ref><ref id="B109"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Lin</surname><given-names>D.</given-names></name><name><surname>Liang</surname><given-names>Z.</given-names></name><name><surname>Song</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Flagellar hooks and hook protein FlgE participate in host microbe interactions at immunological level.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>7</volume>:<issue>1433</issue>. <pub-id pub-id-type="doi">10.1038/s41598-017-01619-1</pub-id>
<?supplied-pmid 28469201?><pub-id pub-id-type="pmid">28469201</pub-id></mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>Z.</given-names></name><name><surname>Xiao</surname><given-names>Y.</given-names></name><name><surname>Kang</surname><given-names>L.</given-names></name><name><surname>Ma</surname><given-names>W.</given-names></name><name><surname>Shi</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Genomic diversity of SARS-CoV-2 in coronavirus disease 2019 patients.</article-title>
<source><italic>Clin. Infect.</italic></source>
<pub-id pub-id-type="doi">10.1093/cid/ciaa203</pub-id>
<comment>[Epub ahead of print]</comment>. <?supplied-pmid 32129843?><pub-id pub-id-type="pmid">32129843</pub-id></mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>Y. Z.</given-names></name><name><surname>Holmes</surname><given-names>E. C.</given-names></name></person-group> (<year>2018</year>). <article-title>Meta-transcriptomics and the evolutionary biology of RNA viruses.</article-title>
<source><italic>Virus Res.</italic></source>
<volume>243</volume>
<fpage>83</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.virusres.2017.10.016</pub-id>
<?supplied-pmid 29111455?><pub-id pub-id-type="pmid">29111455</pub-id></mixed-citation></ref><ref id="B112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirato</surname><given-names>K.</given-names></name><name><surname>Semba</surname><given-names>S.</given-names></name><name><surname>El-Kafrawy</surname><given-names>S. A.</given-names></name><name><surname>Hassan</surname><given-names>A. M.</given-names></name><name><surname>Tolah</surname><given-names>A. M.</given-names></name><name><surname>Takayama</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Development of fluorescent reverse transcription loop-mediated isothermal amplification (RT-LAMP) using quenching probes for the detection of the Middle East respiratory syndrome coronavirus.</article-title>
<source><italic>J. Virol. Methods</italic></source>
<volume>258</volume>
<fpage>41</fpage>&#x02013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/j.jviromet.2018.05.006</pub-id>
<?supplied-pmid 29763640?><pub-id pub-id-type="pmid">29763640</pub-id></mixed-citation></ref><ref id="B113"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soussan</surname><given-names>R.</given-names></name><name><surname>Schimpf</surname><given-names>C.</given-names></name><name><surname>Pilmis</surname><given-names>B.</given-names></name><name><surname>Degroote</surname><given-names>T.</given-names></name><name><surname>Tran</surname><given-names>M.</given-names></name><name><surname>Bruel</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Ventilator-associated pneumonia: the central role of transcolonization.</article-title>
<source><italic>J. Crit. care</italic></source>
<volume>50</volume>
<fpage>155</fpage>&#x02013;<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcrc.2018.12.005</pub-id>
<?supplied-pmid 30551046?><pub-id pub-id-type="pmid">30551046</pub-id></mixed-citation></ref><ref id="B114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tadolini</surname><given-names>M.</given-names></name><name><surname>Codecasa</surname><given-names>L. R.</given-names></name><name><surname>Garc&#x000ed;a-Garc&#x000ed;a</surname><given-names>J.-M.</given-names></name><name><surname>Blanc</surname><given-names>F.-X.</given-names></name><name><surname>Borisov</surname><given-names>S.</given-names></name><name><surname>Alffenaar</surname><given-names>J.-W.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.</article-title>
<source><italic>Eur. Respir. J.</italic></source>
<volume>56</volume>
<issue>2001398</issue>. <pub-id pub-id-type="doi">10.1183/13993003.01398-2020</pub-id>
<?supplied-pmid 32457198?><pub-id pub-id-type="pmid">32457198</pub-id></mixed-citation></ref><ref id="B115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>K.</given-names></name><name><surname>Matsumoto</surname><given-names>K.</given-names></name><name><surname>Furuta</surname><given-names>M.</given-names></name><name><surname>Fukuyama</surname><given-names>S.</given-names></name><name><surname>Takeshita</surname><given-names>T.</given-names></name><name><surname>Ogata</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Periodontal status and lung function decline in the community: the Hisayama study.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>8</volume>:<issue>13354</issue>. <pub-id pub-id-type="doi">10.1038/s41598-018-31610-3</pub-id>
<?supplied-pmid 30190577?><pub-id pub-id-type="pmid">30190577</pub-id></mixed-citation></ref><ref id="B116"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>L.</given-names></name><name><surname>Tang</surname><given-names>X.</given-names></name><name><surname>Pan</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Pan</surname><given-names>Y.</given-names></name></person-group> (<year>2019</year>). <article-title>Relationship among clinical periodontal, microbiologic parameters and lung function in participants with chronic obstructive pulmonary disease.</article-title>
<source><italic>J. Periodontol.</italic></source>
<volume>90</volume>
<fpage>134</fpage>&#x02013;<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1002/jper.17-0705</pub-id>
<?supplied-pmid 30086190?><pub-id pub-id-type="pmid">30086190</pub-id></mixed-citation></ref><ref id="B117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>To</surname><given-names>K. K.-W.</given-names></name><name><surname>Tsang</surname><given-names>O. T.-Y.</given-names></name><name><surname>Leung</surname><given-names>W.-S.</given-names></name><name><surname>Tam</surname><given-names>A. R.</given-names></name><name><surname>Wu</surname><given-names>T.-C.</given-names></name><name><surname>Lung</surname><given-names>D. C.</given-names></name><etal/></person-group> (<year>2020a</year>). <article-title>Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.</article-title>
<source><italic>Lancet Infect. Dis.</italic></source>
<volume>20</volume>
<fpage>565</fpage>&#x02013;<lpage>574</lpage>. <pub-id pub-id-type="doi">10.1016/s1473-3099(20)30196-1</pub-id><pub-id pub-id-type="pmid">32213337</pub-id></mixed-citation></ref><ref id="B118"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>To</surname><given-names>K. K.-W.</given-names></name><name><surname>Tsang</surname><given-names>O. T.-Y.</given-names></name><name><surname>Yip</surname><given-names>C. C.-Y.</given-names></name><name><surname>Chan</surname><given-names>K.-H.</given-names></name><name><surname>Wu</surname><given-names>T.-C.</given-names></name><name><surname>Chan</surname><given-names>J. M.-C.</given-names></name><etal/></person-group> (<year>2020b</year>). <article-title>Consistent detection of 2019 novel coronavirus in Saliva.</article-title>
<source><italic>Clin. Infect. Dis.</italic></source>
<pub-id pub-id-type="doi">10.1093/cid/ciaa149</pub-id>
<comment>[Epub ahead of print]</comment>. <?supplied-pmid 32047895?><pub-id pub-id-type="pmid">32047895</pub-id></mixed-citation></ref><ref id="B119"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres</surname><given-names>A.</given-names></name><name><surname>Niederman</surname><given-names>M. S.</given-names></name><name><surname>Chastre</surname><given-names>J.</given-names></name><name><surname>Ewig</surname><given-names>S.</given-names></name><name><surname>Fernandez-Vandellos</surname><given-names>P.</given-names></name><name><surname>Hanberger</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociaci&#x000f3;n Latinoamericana del T&#x000f3;rax (ALAT).</article-title>
<source><italic>Eur. Respir. J.</italic></source>
<volume>50</volume>:<issue>1700582</issue>. <pub-id pub-id-type="doi">10.1183/13993003.00582-2017</pub-id>
<?supplied-pmid 28890434?><pub-id pub-id-type="pmid">28890434</pub-id></mixed-citation></ref><ref id="B120"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuon</surname><given-names>F. F.</given-names></name><name><surname>Gavrilko</surname><given-names>O.</given-names></name><name><surname>Almeida</surname><given-names>S.</given-names></name><name><surname>Sumi</surname><given-names>E. R.</given-names></name><name><surname>Alberto</surname><given-names>T.</given-names></name><name><surname>Rocha</surname><given-names>J. L.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Prospective, randomised, controlled study evaluating early modification of oral microbiota following admission to the intensive care unit and oral hygiene with chlorhexidine.</article-title>
<source><italic>J. Glob. Antimicrob. Resist.</italic></source>
<volume>8</volume>
<fpage>159</fpage>&#x02013;<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1016/j.jgar.2016.12.007</pub-id>
<?supplied-pmid 28216018?><pub-id pub-id-type="pmid">28216018</pub-id></mixed-citation></ref><ref id="B121"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venkataraman</surname><given-names>A.</given-names></name><name><surname>Bassis</surname><given-names>C. M.</given-names></name><name><surname>Beck</surname><given-names>J. M.</given-names></name><name><surname>Young</surname><given-names>V. B.</given-names></name><name><surname>Curtis</surname><given-names>J. L.</given-names></name><name><surname>Huffnagle</surname><given-names>G. B.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Application of a neutral community model to assess structuring of the human lung microbiome.</article-title>
<source><italic>mBio</italic></source>
<volume>6</volume>:<issue>e02284-14</issue>. <pub-id pub-id-type="doi">10.1128/mBio.02284-14</pub-id>
<?supplied-pmid 25604788?><pub-id pub-id-type="pmid">25604788</pub-id></mixed-citation></ref><ref id="B122"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verweij</surname><given-names>P. E.</given-names></name><name><surname>Gangneux</surname><given-names>J.-P.</given-names></name><name><surname>Bassetti</surname><given-names>M.</given-names></name><name><surname>Br&#x000fc;ggemann</surname><given-names>R. J.</given-names></name><name><surname>Cornely</surname><given-names>O. A.</given-names></name><name><surname>Koehler</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Diagnosing COVID-19-associated pulmonary aspergillosis.</article-title>
<source><italic>Lancet Microbe</italic></source>
<volume>1</volume>
<fpage>e53</fpage>&#x02013;<lpage>e55</lpage>. <pub-id pub-id-type="doi">10.1016/s2666-5247(20)30027-6</pub-id></mixed-citation></ref><ref id="B123"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vlachogiannis</surname><given-names>G.</given-names></name><name><surname>Hedayat</surname><given-names>S.</given-names></name><name><surname>Vatsiou</surname><given-names>A.</given-names></name><name><surname>Jamin</surname><given-names>Y.</given-names></name><name><surname>Fern&#x000e1;ndez-Mateos</surname><given-names>J.</given-names></name><name><surname>Khan</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.</article-title>
<source><italic>Science</italic></source>
<volume>359</volume>
<fpage>920</fpage>&#x02013;<lpage>926</lpage>. <pub-id pub-id-type="doi">10.1126/science.aao2774</pub-id>
<?supplied-pmid 29472484?><pub-id pub-id-type="pmid">29472484</pub-id></mixed-citation></ref><ref id="B124"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>S.</given-names></name><name><surname>Yi</surname><given-names>Q.</given-names></name><name><surname>Fan</surname><given-names>S.</given-names></name><name><surname>Lv</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Guo</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP).</article-title>
<source><italic>medRxiv</italic></source> [<comment>Preprint</comment>] <pub-id pub-id-type="doi">10.1101/2020.02.10.20021832</pub-id></mixed-citation></ref><ref id="B125"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Hu</surname><given-names>B.</given-names></name><name><surname>Hu</surname><given-names>C.</given-names></name><name><surname>Zhu</surname><given-names>F.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus&#x02013;infected pneumonia in Wuhan, China.</article-title>
<source><italic>JAMA</italic></source>
<volume>323</volume>
<fpage>1061</fpage>&#x02013;<lpage>1069</lpage>.</mixed-citation></ref><ref id="B126"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>N.</given-names></name><name><surname>Shi</surname><given-names>H.</given-names></name><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Lin</surname><given-names>L.</given-names></name></person-group> (<year>2003</year>). <article-title>Organism distribution and drug resistance in 7 cases of severe acute respiratory syndrome death patients with secondary bacteria infection.</article-title>
<source><italic>Zhongguo Wei Zhong Bing Ji Jiu Yi Xue</italic></source>
<volume>15</volume>
<fpage>523</fpage>&#x02013;<lpage>525</lpage>.<pub-id pub-id-type="pmid">12971842</pub-id></mixed-citation></ref><ref id="B127"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warinner</surname><given-names>C.</given-names></name><name><surname>Rodrigues</surname><given-names>J. F.</given-names></name><name><surname>Vyas</surname><given-names>R.</given-names></name><name><surname>Trachsel</surname><given-names>C.</given-names></name><name><surname>Shved</surname><given-names>N.</given-names></name><name><surname>Grossmann</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Pathogens and host immunity in the ancient human oral cavity.</article-title>
<source><italic>Nat. Genet.</italic></source>
<volume>46</volume>
<fpage>336</fpage>&#x02013;<lpage>344</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2906</pub-id>
<?supplied-pmid 24562188?><pub-id pub-id-type="pmid">24562188</pub-id></mixed-citation></ref><ref id="B128"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>S. R.</given-names></name></person-group> (<year>2020</year>). <article-title>Forty years with coronaviruses.</article-title>
<source><italic>J. Exp. Med.</italic></source>
<volume>217</volume>:<issue>e20200537</issue>. <pub-id pub-id-type="doi">10.1084/jem.20200537</pub-id>
<?supplied-pmid 32232339?><pub-id pub-id-type="pmid">32232339</pub-id></mixed-citation></ref><ref id="B129"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williamson</surname><given-names>I. A.</given-names></name><name><surname>Arnold</surname><given-names>J. W.</given-names></name><name><surname>Samsa</surname><given-names>L. A.</given-names></name><name><surname>Gaynor</surname><given-names>L.</given-names></name><name><surname>DiSalvo</surname><given-names>M.</given-names></name><name><surname>Cocchiaro</surname><given-names>J. L.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>A high-throughput organoid microinjection platform to study gastrointestinal microbiota and luminal physiology.</article-title>
<source><italic>Cell. Mol. Gastroenterol. hepatol.</italic></source>
<volume>6</volume>
<fpage>301</fpage>&#x02013;<lpage>319</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcmgh.2018.05.004</pub-id>
<?supplied-pmid 30123820?><pub-id pub-id-type="pmid">30123820</pub-id></mixed-citation></ref><ref id="B130"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winning</surname><given-names>L.</given-names></name><name><surname>Patterson</surname><given-names>C. C.</given-names></name><name><surname>Cullen</surname><given-names>K. M.</given-names></name><name><surname>Kee</surname><given-names>F.</given-names></name><name><surname>Linden</surname><given-names>G. J.</given-names></name></person-group> (<year>2019</year>). <article-title>Chronic periodontitis and reduced respiratory function.</article-title>
<source><italic>J. Clin. Periodontol.</italic></source>
<volume>46</volume>
<fpage>266</fpage>&#x02013;<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1111/jcpe.13076</pub-id>
<?supplied-pmid 30712268?><pub-id pub-id-type="pmid">30712268</pub-id></mixed-citation></ref><ref id="B131"><mixed-citation publication-type="journal"><collab>World Health Organization</collab> (<year>2020</year>). <source><italic>Coronavirus Disease (COVID-2019) Situation Report &#x02013; 151.</italic></source> Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200619-covid-19-sitrep-151.pdf?sfvrsn=8b23b56e_2">https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200619-covid-19-sitrep-151.pdf?sfvrsn=8b23b56e_2</ext-link>(<comment>accessed June 19, 2020</comment>)</mixed-citation></ref><ref id="B132"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Guo</surname><given-names>S.</given-names></name><name><surname>Niu</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>B.</given-names></name><name><surname>Jiang</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Heat-shock protein 60 of Porphyromonas gingivalis may induce dysfunction of human umbilical endothelial cells via regulation of endothelial-nitric oxide synthase and vascular endothelial-cadherin.</article-title>
<source><italic>Biomed. Rep.</italic></source>
<volume>5</volume>
<fpage>243</fpage>&#x02013;<lpage>247</lpage>. <pub-id pub-id-type="doi">10.3892/br.2016.693</pub-id>
<?supplied-pmid 27446550?><pub-id pub-id-type="pmid">27446550</pub-id></mixed-citation></ref><ref id="B133"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>F.</given-names></name><name><surname>Zhao</surname><given-names>S.</given-names></name><name><surname>Yu</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>Y. M.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Song</surname><given-names>Z. G.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>A new coronavirus associated with human respiratory disease in China.</article-title>
<source><italic>Nature</italic></source>
<volume>579</volume>
<fpage>265</fpage>&#x02013;<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2008-3</pub-id><pub-id pub-id-type="pmid">32015508</pub-id></mixed-citation></ref><ref id="B134"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wypych</surname><given-names>T. P.</given-names></name><name><surname>Wickramasinghe</surname><given-names>L. C.</given-names></name><name><surname>Marsland</surname><given-names>B. J.</given-names></name></person-group> (<year>2019</year>). <article-title>The influence of the microbiome on respiratory health.</article-title>
<source><italic>Nat. Immunol.</italic></source>
<volume>20</volume>
<fpage>1279</fpage>&#x02013;<lpage>1290</lpage>. <pub-id pub-id-type="doi">10.1038/s41590-019-0451-9</pub-id>
<?supplied-pmid 31501577?><pub-id pub-id-type="pmid">31501577</pub-id></mixed-citation></ref><ref id="B135"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Zhong</surname><given-names>L.</given-names></name><name><surname>Deng</surname><given-names>J.</given-names></name><name><surname>Peng</surname><given-names>J.</given-names></name><name><surname>Dan</surname><given-names>H.</given-names></name><name><surname>Zeng</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa.</article-title>
<source><italic>Int. J. Oral Sci.</italic></source>
<volume>12</volume>
<fpage>1</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">31900382</pub-id></mixed-citation></ref><ref id="B136"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>F.</given-names></name><name><surname>Huang</surname><given-names>Z.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Pan</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Meeting report: a close look at oral biofilms and microbiomes.</article-title>
<source><italic>Int. J. Oral Sci.</italic></source>
<volume>10</volume>:<issue>28</issue>. <pub-id pub-id-type="doi">10.1038/s41368-018-0030-1</pub-id>
<?supplied-pmid 30111787?><pub-id pub-id-type="pmid">30111787</pub-id></mixed-citation></ref><ref id="B137"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Shi</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Pathological findings of COVID-19 associated with acute respiratory distress syndrome.</article-title>
<source><italic>The Lancet Respiratory Medicine</italic></source>
<volume>8</volume>
<fpage>420</fpage>&#x02013;<lpage>422</lpage>. <pub-id pub-id-type="doi">10.1016/s2213-2600(20)30076-x</pub-id><pub-id pub-id-type="pmid">32085846</pub-id></mixed-citation></ref><ref id="B138"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Sun</surname><given-names>A.</given-names></name><name><surname>Peng</surname><given-names>Y.</given-names></name></person-group> (<year>2020</year>). <article-title>2019 novel coronavirus (2019-nCoV) and 2019-nCoV pneumonia.</article-title>
<source><italic>Chin. J. Microbiol. Immunol.</italic></source>
<volume>40</volume>:<issue>E001</issue>.</mixed-citation></ref><ref id="B139"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>Z. M.</given-names></name><name><surname>Sun</surname><given-names>G. Y.</given-names></name><name><surname>Zhou</surname><given-names>P.</given-names></name><name><surname>Han</surname><given-names>X. L.</given-names></name></person-group> (<year>2018</year>). <article-title>Clinical significance of interleukin-6 and -8 in patients with chronic periodontal disease and acute exacerbation of chronic obstructive pulmonary disease.</article-title>
<source><italic>Zhonghua kou qiang yi xue za</italic></source>
<volume>53</volume>
<fpage>312</fpage>&#x02013;<lpage>317</lpage>. <pub-id pub-id-type="doi">10.3760/cma.j.issn.1002-0098.2018.05.005</pub-id>
<?supplied-pmid 29972988?><pub-id pub-id-type="pmid">29972988</pub-id></mixed-citation></ref><ref id="B140"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Shen</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Yuan</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections.</article-title>
<source><italic>medRxiv[Preprint]</italic></source>
<pub-id pub-id-type="doi">10.1101/2020.02.11.20021493</pub-id></mixed-citation></ref><ref id="B141"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>L.</given-names></name><name><surname>Tong</surname><given-names>Y.</given-names></name><name><surname>Shen</surname><given-names>G.</given-names></name><name><surname>Fu</surname><given-names>A.</given-names></name><name><surname>Lai</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Immunodepletion with Hypoxemia: a potential high risk subtype of coronavirus disease 2019.</article-title>
<source><italic>medRxiv[Preprint]</italic></source>
<pub-id pub-id-type="doi">10.1101/2020.03.03.20030650</pub-id></mixed-citation></ref><ref id="B142"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Porter</surname><given-names>E.</given-names></name><name><surname>Lu</surname><given-names>N.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Yuan</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Development of a multiplex real-time RT-PCR assay for simultaneous detection and differentiation of influenza A, B, C, and D viruses.</article-title>
<source><italic>Diagn. Microbiol. Infect. Dis.</italic></source>
<volume>95</volume>
<fpage>59</fpage>&#x02013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2019.04.011</pub-id>
<?supplied-pmid 31130238?><pub-id pub-id-type="pmid">31130238</pub-id></mixed-citation></ref><ref id="B143"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>N.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Deng</surname><given-names>X.</given-names></name><name><surname>Liang</surname><given-names>R.</given-names></name><name><surname>Su</surname><given-names>M.</given-names></name><name><surname>He</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Recent advances in the detection of respiratory virus infection in humans.</article-title>
<source><italic>J. Med. Virol.</italic></source>
<volume>92</volume>
<fpage>408</fpage>&#x02013;<lpage>417</lpage>. <pub-id pub-id-type="doi">10.1002/jmv.25674</pub-id>
<?supplied-pmid 31944312?><pub-id pub-id-type="pmid">31944312</pub-id></mixed-citation></ref><ref id="B144"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Zhao</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name></person-group> (<year>2004</year>). <article-title>Detection and drug resistance of secondary infection bacteria in patients with severe acute respiratory syndrome (SARS).</article-title>
<source><italic>Chin. J. Nosocomiol.</italic></source>
<volume>14</volume>
<fpage>1121</fpage>&#x02013;<lpage>1123</lpage>.</mixed-citation></ref><ref id="B145"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Luo</surname><given-names>J.</given-names></name><name><surname>Dong</surname><given-names>X.</given-names></name><name><surname>Zhao</surname><given-names>S.</given-names></name><name><surname>Hao</surname><given-names>Y.</given-names></name><name><surname>Peng</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Salivary microbial dysbiosis is associated with systemic inflammatory markers and predicted oral metabolites in non-small cell lung cancer patients.</article-title>
<source><italic>J. Cancer</italic></source>
<volume>10</volume>
<fpage>1651</fpage>&#x02013;<lpage>1662</lpage>. <pub-id pub-id-type="doi">10.7150/jca.28077</pub-id>
<?supplied-pmid 31205521?><pub-id pub-id-type="pmid">31205521</pub-id></mixed-citation></ref><ref id="B146"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name><name><surname>Zuo</surname><given-names>W.</given-names></name></person-group> (<year>2020</year>). <article-title>Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov.</article-title>
<source><italic>bioRxiv</italic></source> [<comment>Preprint</comment>] <pub-id pub-id-type="doi">10.1101/2020.01.26.919985</pub-id></mixed-citation></ref><ref id="B147"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>R.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name></person-group> (<year>2003</year>). <article-title>The clinical characteristics of secondary infections of lower respiratory tract in severe acute respiratory syndrome.</article-title>
<source><italic>Chin. J. Respir. Crit. Care Med.</italic></source>
<volume>2</volume>
<fpage>270</fpage>&#x02013;<lpage>274</lpage>.</mixed-citation></ref><ref id="B148"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>P.</given-names></name><name><surname>Yang</surname><given-names>X.-L.</given-names></name><name><surname>Wang</surname><given-names>X.-G.</given-names></name><name><surname>Hu</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>A pneumonia outbreak associated with a new coronavirus of probable bat origin.</article-title>
<source><italic>Nature</italic></source>
<volume>579</volume>
<fpage>270</fpage>&#x02013;<lpage>273</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2012-7</pub-id>
<?supplied-pmid 32015507?><pub-id pub-id-type="pmid">32015507</pub-id></mixed-citation></ref><ref id="B149"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>N.</given-names></name><name><surname>Zhang</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>B.</given-names></name><name><surname>Song</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>A novel coronavirus from patients with pneumonia in China, 2019.</article-title>
<source><italic>New Engl. J. Med.</italic></source>
<volume>382</volume>
<fpage>727</fpage>&#x02013;<lpage>733</lpage>.<pub-id pub-id-type="pmid">31978945</pub-id></mixed-citation></ref><ref id="B150"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Ge</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>T.</given-names></name><name><surname>Zhao</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Co-infection with respiratory pathogens among COVID-2019 cases.</article-title>
<source><italic>Virus Res.</italic></source>
<volume>285</volume>:<issue>198005</issue>. <pub-id pub-id-type="doi">10.1016/j.virusres.2020.198005</pub-id>
<?supplied-pmid 32408156?><pub-id pub-id-type="pmid">32408156</pub-id></mixed-citation></ref><ref id="B151"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zumla</surname><given-names>A.</given-names></name><name><surname>Hui</surname><given-names>D. S.</given-names></name><name><surname>Azhar</surname><given-names>E. I.</given-names></name><name><surname>Memish</surname><given-names>Z. A.</given-names></name><name><surname>Maeurer</surname><given-names>M.</given-names></name></person-group> (<year>2020</year>). <article-title>Reducing mortality from 2019-nCoV: host-directed therapies should be an option.</article-title>
<source><italic>Lancet</italic></source>
<volume>395</volume>
<fpage>e35</fpage>&#x02013;<lpage>e36</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(20)30305-6</pub-id><pub-id pub-id-type="pmid">32035018</pub-id></mixed-citation></ref><ref id="B152"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuo</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Lui</surname><given-names>G. C. Y.</given-names></name><name><surname>Yeoh</surname><given-names>Y. K.</given-names></name><name><surname>Li</surname><given-names>A. Y. L.</given-names></name><name><surname>Zhan</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Alterations in gut microbiota of patients with COVID-19 during time of hospitalization.</article-title>
<source><italic>Gastroenterology</italic></source>
<pub-id pub-id-type="doi">10.1053/j.gastro.2020.05.048</pub-id>
<comment>[Epub ahead of print]</comment>. <?supplied-pmid 32442562?><pub-id pub-id-type="pmid">32442562</pub-id></mixed-citation></ref></ref-list></back></article>